ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000202.1|Azicemicin_1 # 1 # 507 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.675	BGC0000202.1|Azicemicin_1 	1	507	+	Loose	605	27.335	FRI-9	52.17	3005032	protein homolog model	n/a	n/a	penam	antibiotic inactivation	FRI beta-lactamase	GTCGACGAATGGCGCGGCCAGAGTGCGCAGGCCTTCGACGCACACCGGGAAACCATGAAAGGACAGGTGAAAACAGCCCGAATCGCGTTCGACGACACCGCGGAAGCGCTGGACCGTTACCGCGAGACGCTGATCACAGTCCAGAGCCTGGCCAAGTACGCGATCCAGCGCGCCCAGCATGACGGAAACTGGGTCCGCGCGAACGAGGACATCGACCTGTGGCGTGGCCAGAACTCAGCCGAGGCCGCCATCGCCGCGAGAGACCTGCAGGACGCGACCGGTCGGCTGCGGAGCATCTCGGCGCTCGTCACCGACCGCGTCCCGGACGCACCCACGCCGAATCCTCCGCTGGGATCTGTCATCCGGCTGAAGAAGTCCGACAGACAGCGTCCCACGCACCGGCCCGTCACCCCGGAGGACGAGACGCCGCGGATGCGCCACGACCGCATCCGCGCGCTCTGCGACGCGGTACTCGACGCCTCGTACGTCAGTGCCGACGACCTGTGA	VDEWRGQSAQAFDAHRETMKGQVKTARIAFDDTAEALDRYRETLITVQSLAKYAIQRAQHDGNWVRANEDIDLWRGQNSAEAAIAARDLQDATGRLRSISALVTDRVPDAPTPNPPLGSVIRLKKSDRQRPTHRPVTPEDETPRMRHDRIRALCDAVLDASYVSADDL	MFFLKKSASTFVFLLCLPLNSFASQESNGVEQMKELENSFGGRIGVYILNTKNGKEFSYRQDERFPLCSSFKAFLAASVLKRTQDKSVSLDDMMEYSGRVMEKHSPVSEKYRETGASVQTLAKAAIQYSDNGASNLLMERYIGGPEGLTAFMRSTGDTDFRLDRWELELNSAIPGDERDTSTPKTVAMSLNNIAFGSVLDAKNKSLLQDWLKGNTTGNARIRAAVPDKWVVGDKTGTCGFYGTANDIAILWPDANSPAVMAVYTTRPNQNDKHDETVIKNAAKIAINAVYGSTK	57.14	gnl|BL_ORD_ID|2819|hsp_num:0	3771		
BGC0000202.1|Azicemicin_2 # 517 # 1161 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=7bp;gc_cont=0.713	BGC0000202.1|Azicemicin_2 	517	1161	-	Loose	390	81.6481	evgA	23.86	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCGGCCCGGTGATCAAACTGCTGATCGTCGACGACCACCCGGTCGTCCGGGACGGGTTGAGCGGCCTGTTCGGCCGTGACCCGGACTTCGAGGTCGTCGGCGAGGCAGCGGACGGAGCCGAGGCGGTCCGCCTCGCCGAGCAGTTGCGTCCCGACGTGATCCTCATGGACCTGCGCATGCCCGGGATGGACGGCGTCGCCGCGACGAGAGAGCTCGCCGGGCGAGGACGCGTGCTCGTGCTCACCACGTACGACACCGAAACGCACGTGCTGCCCGCGATCGAGGCAGGCGCCACCGGCTACCTGCTCAAGGACGCGCCCCGCGACGAGCTCCTGCGCGCGGTCCGCGCCACGGCACGCGGCGAGGCAGTCCTCGCTCCGTCAGCGGCCGCGCTGCTGATGAGCCGGGTCCGCGCGTCCGCCGCCGGGCCACTGAGCCAACGGGAACTCGAAGTCCTCCACCTGGTGGCCGAGGGCGCCACGAACCGTGAGGCAGCGGCGAGACTGTTCCTCACCGAGGCGACCATCAAGTCACACCTGCTGAACATCTACGGCAAGCTCGGCGTCAGCGACCGCGCCGCCGCCGTCACCGCGGGCTTCAACCGCGGACTGCTCGTCCCACGGGCACCGGAGAAGCCCTGA	MSGPVIKLLIVDDHPVVRDGLSGLFGRDPDFEVVGEAADGAEAVRLAEQLRPDVILMDLRMPGMDGVAATRELAGRGRVLVLTTYDTETHVLPAIEAGATGYLLKDAPRDELLRAVRATARGEAVLAPSAAALLMSRVRASAAGPLSQRELEVLHLVAEGATNREAAARLFLTEATIKSHLLNIYGKLGVSDRAAAVTAGFNRGLLVPRAPEKP	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	104.90	gnl|BL_ORD_ID|958|hsp_num:0	1015		
BGC0000202.1|Azicemicin_3 # 1158 # 2372 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGGAG;rbs_spacer=8bp;gc_cont=0.716	BGC0000202.1|Azicemicin_3 	1158	2372	-	Loose	2300	35.8094	evgS	36.11	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCGGACGGTCGGTGGTGACCGGCGTCGTGCCGTACACCCTGCTGGGGCTCCTGGCCGTCGTCACGGTGCCCATCAGGTGGTCGGACGGCCAGTCCCCGGCGGTCGACCTGGTGCTGTGCGCGCTCGCGGCGACGTGGATGCTGTGGGTCTTCACGCTGCACCCAGCCTGGCGGGAACGCCCGTTCGTGATGGCGGTGTTCTTCACCGTGCTGATCGTGATCATGGCTGTCCTGGTGGTCAGAGCACCGTGGTTCGGGTTCTTCACGCCAGCCGGGTACATCTTCGCGTTCCGCGTGCTGAGGTGGCCGTGGCAGGTGGTCGCCGTCGCCGCGGTGGCCGTGCTGGCGGGCACCGCGCAGGCGTATGACGTGGACAAGGGCACGACCCTGGGTGTGCTCACCTACCTCGCGGTCGTGGTCGCGAACGTGTTGCCCATGTGCGCGTTCGCCTGGTTTGCCCAACGCGGCGAGTTGCGTAACGAGGAACGCGTGCGCGCTCTGGCCGACGCCCGGGAAGCCAACCGCAGGCTGGCGGAGACGCTCGCGGAGAACGAGGCTCTGCACGAGCAACTCGTCACGCAGGCCCGCCAGGCAGGCGTGCGTGACGAGCGGCAGCGGATGGCACGGGAAATCCACGACACCCTGGCCCAGGGACTGACCGGGATCATCAGCCAGCTGCGCGCGGCCGAACACGCGGGCGACGACCCAGCGGGCTGGCGCAGGCACCTCGCCGCCGCGACCGGGCTGGCCAGGGAGAGCCTGCAGGAGGCACGGCGCTCGGTGCACGCGCTGCGCCCCGAGCCGCTGCGGACTGCGCGACTCGGCGAGGCACTGGGCAGCGTGGCGGACCGCTGGTCCACGCTGAACGGCATCCCGGTCCAGGTCACGACGACCGGAACCGCGTCGCCCATGCGGCCGGAGGCCGAGGTCGCCCTGCTCAGAGCCGCGCAGGAAGCGCTGTCCAACGTGGCCAAGCACGCGCGGGCGAGCCGGGTGGGGGTGACACTGTCGTACATGGAACACGAGGTGGCCTTGGACGTGCGGGACGACGGCGGCGGCTTCGACCCGGCACTGCCGGGCAACCCGGGGTTCGGCCTGGTCGCCATGCGGCAGCGGATCGAGGGCCTGTCCGGCTCGCTGCAGGTCGAATCGGAGCCCGGCGCGGGCACGGGAATCTCGGCCCGCGTTCCCCTCGCGGAGGCCACCGCGTGA	MRGRSVVTGVVPYTLLGLLAVVTVPIRWSDGQSPAVDLVLCALAATWMLWVFTLHPAWRERPFVMAVFFTVLIVIMAVLVVRAPWFGFFTPAGYIFAFRVLRWPWQVVAVAAVAVLAGTAQAYDVDKGTTLGVLTYLAVVVANVLPMCAFAWFAQRGELRNEERVRALADAREANRRLAETLAENEALHEQLVTQARQAGVRDERQRMAREIHDTLAQGLTGIISQLRAAEHAGDDPAGWRRHLAAATGLARESLQEARRSVHALRPEPLRTARLGEALGSVADRWSTLNGIPVQVTTTGTASPMRPEAEVALLRAAQEALSNVAKHARASRVGVTLSYMEHEVALDVRDDGGGFDPALPGNPGFGLVAMRQRIEGLSGSLQVESEPGAGTGISARVPLAEATA	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	33.75	gnl|BL_ORD_ID|1243|hsp_num:0	1318		
BGC0000202.1|Azicemicin_4 # 2414 # 4030 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=7bp;gc_cont=0.697	BGC0000202.1|Azicemicin_4 	2414	4030	-	Loose	700	26.1794	ACT-37	35.71	3003172	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGAGTCAGTCGGAGCGCGCCCAGGTAAGCCGCCGGATGCTGCTCGCGGGCGCGGGAGCCGTGGCAGCCGGAACGTGGGGGACAGGACAGGCGGCTGCCGAGGCCGCTGGGATCGGCGGGATCGGCGCCGTGCGGATCAAGCCTGGCGACCTGCGGTACGACAGCCTGCTGCGGGGCAACAACTTCCGGTTCGTCGGTCGGCCGGACGAGATCCGTGTCGCGAGCTCGACCGACGACGTGGTGCGTGCCGTCGCCGATTCGGTGCGGGCCGGGCGACGGGTCGCGGTCCGCAGCGGCGGACACTGCTTCGAGAACTTCACCGCCAACCCGGCCGTGCGAACGCTGCTCGACCTGTCACCGATGGATGACGTCGGCTACGACCCTGGCATGCGGGCGTTCGCGGTCCAGCCAGGGGCAACGCTGGGCAAGGTGTACCGGAGGTTGTTCACGGGCTGGGGTGTGACGATTCCCGGCGGCGGCTGTCCGGCGGTGGGCGCGGGCGGCCACTTCGCGGGCGGCGGGTACGGGCCGCTGTCCCGCCGGTACGGCTCGGTGGTTGACCACCTGTACGGCGTGGAGGTCGTGGTGGTCGACCGCGACGGCACCGCCCGCGCGGTGGTAGCCACGCGCGAACCCAACGACCCGCACCGAGACCTGTGGTGGGCGCACACCGGCGGGGGCGGCGGCAATTTCGGCGTGGTCACCCGGTACTGGCTGCGCTCACCCGGCGCCACAGGCGCACCGTCCCAACTGCTGCCCGCCGCGCCGCAACAGGTGCTCGAATGCGTGGTCGCCTGGTCATGGGAAGGCATGACCGAGCAGGTGTTCACCAGGCTGCTGCGCAACTTCGGCACGTGGCACGAGCGCAACAGCGCACCGGGCGACCGGTCGGCGGGCCTGTACGGAATCCTCCTGCTGTCCCACCGCAAAGCCGGGTATTTCACGCTGGTCGTGCAGATGGACGCGGGTCTGCCGGGCGCGGACGGGATCGTGACCGACTTCGTGGCCGCGGTGACCGAGGGGACCGGCGAGGTCAAGCCGATCGTCAACGAGCGTAGGACGCTGCCCTGGCTGCACGAGATGACCTGGCCGGGCACCGGCGAGTCCGGTGACTCGGTCGCGCGCCGGTACAAGATCAAAGCCGGGTATCTGCGCAGGTCAATGACGGACAAGCAGATCGCCGCGGTGCACCGCAACCTGACGAACACCACCGGCAGCGCCGAGTCGCACATGCTGCTCATCGGCTACGGCGGCCAAGTGCGCGCGGTGCCGTCAGAGGCGACCGCGGTCGCTCAACGTGACGTGGTCATGAAAGCGGTCTACAGCACGGGCTGGGCCGACGAGGCCGACGACGCGGCCAACCTCGCCTGGATACGCGAGTTCTACCGCGACGTGTACGCGGACACCGGAGGTGTGCCCGTCCCCAACGAGGTCAACGACGGCTCATACATCAACTACCCCGACAACGACCTGGTCGACCCAGCGTGGAACACCTCCGGTGTGCCGGGACGCATCCTCTACTACAAGGACAACTACCCACGTCTGCGGCAGGCCAAGGCCCGGTGGGACCCGCGTGGCGTGTTCCAGCACGCGCTGTCCATCGAGCCACCGGCCTGA	MSQSERAQVSRRMLLAGAGAVAAGTWGTGQAAAEAAGIGGIGAVRIKPGDLRYDSLLRGNNFRFVGRPDEIRVASSTDDVVRAVADSVRAGRRVAVRSGGHCFENFTANPAVRTLLDLSPMDDVGYDPGMRAFAVQPGATLGKVYRRLFTGWGVTIPGGGCPAVGAGGHFAGGGYGPLSRRYGSVVDHLYGVEVVVVDRDGTARAVVATREPNDPHRDLWWAHTGGGGGNFGVVTRYWLRSPGATGAPSQLLPAAPQQVLECVVAWSWEGMTEQVFTRLLRNFGTWHERNSAPGDRSAGLYGILLLSHRKAGYFTLVVQMDAGLPGADGIVTDFVAAVTEGTGEVKPIVNERRTLPWLHEMTWPGTGESGDSVARRYKIKAGYLRRSMTDKQIAAVHRNLTNTTGSAESHMLLIGYGGQVRAVPSEATAVAQRDVVMKAVYSTGWADEADDAANLAWIREFYRDVYADTGGVPVPNEVNDGSYINYPDNDLVDPAWNTSGVPGRILYYKDNYPRLRQAKARWDPRGVFQHALSIEPPA	MMKKSFCCALLLAISGAALAAPVSEKQLAEVVANTVTPLMKAQAIPGMAVAVIYQGKPHYYTFGEADIAAKKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVIKYWPELTGKQWQGIRMLDLATYTAGGLPLQVPEEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGALAVKPSGMRYEQAMTKRVFKPLRLNHTWINVPKAEAAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEAKTVIEGSDNKVALAPLPVAEVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ	141.21	gnl|BL_ORD_ID|238|hsp_num:0	257		
BGC0000202.1|Azicemicin_5 # 4262 # 4960 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=7bp;gc_cont=0.701	BGC0000202.1|Azicemicin_5 	4262	4960	+	Loose	500	24.6386	OXA-248	23.73	3001673	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGCTGCACATAGGAATACTCGGCCACTCGGTTCCGGGCTCGGCGCACTGCTACCAGTCGATCACCCGGTATGGCGAGGAACGCCTTGGGGCATACCAGCATCCGGACATCACTCTCGACTGCGTTCCGATGGGACGCAGCATGCCCGCGTGGGAGTCCGGCGACCGCGCCGCCGTGCGGGCCATCCTCGCCGAGAGCGTCGAGCGGCTGGCACGGGCAGGGTGCGACTTCTACGTCTGCCCGGACAACACCGCGCATCTCGCCCTTGACCTTCCCGGTCCCGCGCTGGCGTTGCCGGGGCTGCACATCGCGGAGGTCGTCGCCGCGGAGGCCGCCGCGCGAGGCTTCCGGTGCGTCGGGGTTCTCGGCACTCGCTGGACGATGACCGCGTCGATGTACCCGGAGGCGTTCGCCGCGCACAGCATCGCCAGCAGGGCACCGTCTCCCGCCGACCAGGACGACATCCAGCGGATCACGTTCGACGAACTCGTGCGCGGAGTCTTCACCTCGGCGGCCCGGGACCGTTTCGCGGCCGTCGTCGACACCCTGCGGGCGGACGGCTGCGACGCCGTGGCGCTGGTCTGCACCGAGCATCCGCTACTGCTCACACCGGACGCCTCTCCCCTGCCGACGCTCAACTCCACCGAACTGCTGGCACGGGCCGCCGTTGAGGCCGCGCTGGCGGACAACGTCACCTGA	MLHIGILGHSVPGSAHCYQSITRYGEERLGAYQHPDITLDCVPMGRSMPAWESGDRAAVRAILAESVERLARAGCDFYVCPDNTAHLALDLPGPALALPGLHIAEVVAAEAAARGFRCVGVLGTRWTMTASMYPEAFAAHSIASRAPSPADQDDIQRITFDELVRGVFTSAARDRFAAVVDTLRADGCDAVALVCTEHPLLLTPDASPLPTLNSTELLARAAVEAALADNVT	MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTLGDAMKASAMPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	84.67	gnl|BL_ORD_ID|1120|hsp_num:0	1187		
BGC0000202.1|Azicemicin_6 # 4986 # 6770 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGGGGA;rbs_spacer=7bp;gc_cont=0.691	BGC0000202.1|Azicemicin_6 	4986	6770	-	Loose	920	28.8758	OpmD	39.02	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGACTGGGACCGGATCGACAAGCTGATACGAACCCGGGAGTACGACGAACTGCTCGCCGTGGCCCGTGGTCTCGACGATGCCGACCGCAAGGCGCTGGTCGGCCCGCTCAAGGAGTTCGAACGGCATGCCCGTTCGGGCGAGGCGGACCTGTGGCACTCGAGAAGCTGTTTCGCGATCATCGGCGCGGGTGTCCTGACCGGCGCGTCGGTGCTCGCTCCATGGCTGGTGCGCAATGGTTTCCGGGACACCATCAACCCCTTCCAAACTCGGCGCCAGTCCGCTGACCTGGCCGACAGCGTGCTGGACATCCTGGAAGTCAGGGACGTGCCGTGGTTGCCTGATCTGGCGCGGAGACTGGCTGATCGGCTGTCGGCCAGTCGATTCGACTGGGGTCAGTTCCGGATGGTCACGAACCTGGTGAAACTGACGGGCATCGATCCGCCGCCGACTGACGGGCTGGTGCTCGGCCTGGCGGCGGAGGGCAACTGGGCGGACAGGGCCCTCGGTGACCCGCGATGGCTGGCGGTCGTGCCTCGGATGTTCGAGGTCGCCGGAGTCGGGCGGATCATCGAGGAGTCCGCGTACTTCGAAGTGGGCTGGCCACAGCGGATCGCCGAACTCGCGGCGAACGGAAAGCTCGATCGCGGCATGATGATCGACGGCGCGATCGCCGCACTGCAACGAGGCGGCCGCCTCGGCGACGTCCGCGGATTTCTGAAGGTCTACGAGGCGCTCGAACCGGACCTGCCCGAGATCGTCGACCGGCTGCGCGACTACGTGCCGATCCTGGCGGACGCCCATTCTTCGGTGGCGGGCGTCGCGCAGCGCGAGTTGTTCCGTGCGGACGACGCCGGGAAGCTGCCGGTCGATCTCCTGCTCGATGTCAGCCACGCGGTGTTCCTGCGCTCGGAGAAGAAACTGGTCAGGGCGCAGCTTGACCGGCTCGACAGGGTGATCGGCCGTGAGCCTGGCCGTGTCGACGACGTACTGCTCGCGCTCGGCGTGGTGTTCGAGCACGACGCGGCGGACATCCAGGCCAAAGCACTGGACGTGGTGCTCGCGCACGCCTCCGCCGTGGCACAGCGGACCAGGGACGAGCTCGCCGCGGTGGCGAGCGCGCTGCCCGCGGACCTCAGGGCCAAAGCCGCCAAGGCGCTCGGCACGGTCGACGCCCCACAGACGCTGATGACCACGCTGCCGCCCGTGCCGGAGGCGCCGGTGCTCCCGACTCCTGTCGGGTCGCTGGCCGACATCGTGGTGTTCCTGTATGGGAGGACTCTGCGCGGACGCGGCGGCGGTCGGATGCTCACCACACTCAGCCACACCGTCGACCAGATGGGCGAAGACTGCGCGCGGGCGTTCGCTCACGGCTTGGACGCCCACGACAAGAACGACCGCGCCGAAGCCGTCGATGCCCTGCTCGTCCTGGCCGCCCGCGACCGCTGGAACCCGGCAGCGCTCGGGCAGCAGATCGGTGTCCTCGCGGCCGACGTGGAACTGAGCCTGAACCGAGTCGTGCCGTGCCTGCGTGACCTGGCCCAATCGGGCGCGGCCAGCCAGGTCTGGGGCACTGTCGCCGCCGCTCTGCCGCCCATGCTGTCGCCGGAGCTCGAACGTCCGCCCCAGCGCCTCGCCGACCTGCTGGCCCTGGCTGTGGAACTTGTCGAACAGGTCCGTCCCACCACGTCCATCCCCGGACTGGCGGACGTGGCCGCCCGCCGTGGCGGCAGCCGCATCGTCACCGAGGCCAAACGCCTTGAGGCGGCCTTACCTGGCTGA	MSDWDRIDKLIRTREYDELLAVARGLDDADRKALVGPLKEFERHARSGEADLWHSRSCFAIIGAGVLTGASVLAPWLVRNGFRDTINPFQTRRQSADLADSVLDILEVRDVPWLPDLARRLADRLSASRFDWGQFRMVTNLVKLTGIDPPPTDGLVLGLAAEGNWADRALGDPRWLAVVPRMFEVAGVGRIIEESAYFEVGWPQRIAELAANGKLDRGMMIDGAIAALQRGGRLGDVRGFLKVYEALEPDLPEIVDRLRDYVPILADAHSSVAGVAQRELFRADDAGKLPVDLLLDVSHAVFLRSEKKLVRAQLDRLDRVIGREPGRVDDVLLALGVVFEHDAADIQAKALDVVLAHASAVAQRTRDELAAVASALPADLRAKAAKALGTVDAPQTLMTTLPPVPEAPVLPTPVGSLADIVVFLYGRTLRGRGGGRMLTTLSHTVDQMGEDCARAFAHGLDAHDKNDRAEAVDALLVLAARDRWNPAALGQQIGVLAADVELSLNRVVPCLRDLAQSGAASQVWGTVAAALPPMLSPELERPPQRLADLLALAVELVEQVRPTTSIPGLADVAARRGGSRIVTEAKRLEAALPG	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	121.97	gnl|BL_ORD_ID|410|hsp_num:0	442		
BGC0000202.1|Azicemicin_7 # 6767 # 8161 # -1 # ID=1_7;partial=00;start_type=TTG;rbs_motif=AGGG;rbs_spacer=3bp;gc_cont=0.701	BGC0000202.1|Azicemicin_7 	6767	8161	-	Loose	700	28.4906	Klebsiella pneumoniae KpnH	28.79	3004597	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGCCGGAGATCCGGAAACTGTCGGACCCCGCCCCTACAGTGCCCGTCATGACTGCTGTCGCACGGGAATACCGCTACCTGCGCTCGTCGGAACTGTCCGGCGGGCTGCTCGGGCTGCAGACATCGGGTGGCACGGCGCTGCGCGGTCCGGTGCGGAACCCTTTGTTCTTCAAGGGGTTCCTCACCGAACCGGCGGCAGCGGCGGCGAGCCTGCACTCGGTGGCCAAGGTCGCGGCGAGCAGGTACTTCCAACCGACGCGGGTGCGTCTGCCGACGCAGGTGAGCCTGCGGGATCCGGTGGTCACCTGCAACGGCGATCGGCTGCGGTTCGAGTCGTTCGCTGGCTGTTGCGGCGTCTACGCCAGGCTCGATGTGCTCGCGGGCGGGCTCGACGGCGAGGTCCTCGACCGGGGAACCACGAACGTCGACGTGAACGAGCCGTTGCGGCGCATGCTCGCCCGCGTGGGCGCCGGTGATCCGCTCCGGTTCGCGGTCGGCCCCGACGAGGTCACAGTGACCACAATGGACGGTTCGGCGGTCGAGAAGAAGGTCGAGCTCCCGCAGCGGTGGCTGCGCGGCTTCGCGGAACTGCAGGTGATCACGGCCGGTTTCGAGCCACGGCTGGAGATCCCGGTCGCTGAGGCGGCTCGGTTCCTCCGGTCGTTGTCCTCGTCGCGCTCGCGCGGGGCATCGTGGGCGGTCCCGGCCGGACGGTCGCTGCGCCTGTCGGCGCGGCCCGCCGCGGGAGCGGTGTGCCTGGCCGGACCACAACGCCTTGAGGCGCTGACTCCGCTGCTGCGTCACGCGAGGTCGCTGCGAGTGTACGGCCCTGCGGTGAACGCGAGCAGCCTGCCTTGCGCGAGCGCGTGGGAGCTCGCTCTACCGGGGATGACGTTCGTCCTGGTGCTGTCACCGGAGGTGAACAGGGGGTTCTCCGGGGAGGGCGCGGTGCTGGACTTCCTCGCGGGAGACGAAGCCGGGCAGGACGCGGAGCTGATCGGGGCACTGCTCGAGTTCGAGGCGAGGGTGGAGCCCGCCGAGTTGGCCGAGCGGTCGGGGCTGCCGCGCGACCGTGTCCGTTCCGCACTGGTCCAACTCGGCGTGAGTGGCCGCGTGGGCTACGACCTGGCCGAGGCCTCGTACTTTCACCGGGAACTGCCGTACGACGCGGAATCCGTCGAACAGTTCAACCCAAGGCTGCGCAACGCCAGGGCGCTGGTGGCGGCCGGAGCGGTGACGGGCGAGGGCGATGTGCTGACGGTCAAGGGCTACCAGGTCCGGTTCACGGGGACCGACGCGTCCTGCACCTGCGCGTGGTGGCGGGATTACCGCGGCACCCGAGGCAAATGCAAACACGTGCTGGCGGCGGAGATCTCACGGGGGAGTGCGGGATGA	MPEIRKLSDPAPTVPVMTAVAREYRYLRSSELSGGLLGLQTSGGTALRGPVRNPLFFKGFLTEPAAAAASLHSVAKVAASRYFQPTRVRLPTQVSLRDPVVTCNGDRLRFESFAGCCGVYARLDVLAGGLDGEVLDRGTTNVDVNEPLRRMLARVGAGDPLRFAVGPDEVTVTTMDGSAVEKKVELPQRWLRGFAELQVITAGFEPRLEIPVAEAARFLRSLSSSRSRGASWAVPAGRSLRLSARPAAGAVCLAGPQRLEALTPLLRHARSLRVYGPAVNASSLPCASAWELALPGMTFVLVLSPEVNRGFSGEGAVLDFLAGDEAGQDAELIGALLEFEARVEPAELAERSGLPRDRVRSALVQLGVSGRVGYDLAEASYFHRELPYDAESVEQFNPRLRNARALVAAGAVTGEGDVLTVKGYQVRFTGTDASCTCAWWRDYRGTRGKCKHVLAAEISRGSAG	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLILLGLVWFAKPPFGAGGGGGGAH	90.62	gnl|BL_ORD_ID|2791|hsp_num:0	3299		
BGC0000202.1|Azicemicin_8 # 8353 # 9657 # -1 # ID=1_8;partial=00;start_type=TTG;rbs_motif=GGGA;rbs_spacer=5bp;gc_cont=0.676	BGC0000202.1|Azicemicin_8 	8353	9657	-	Loose	1000	25.7942	Clostridium perfringens mprF	25.0	3003773	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	TTGACGCAGACTTGCGGCCGCCCTTGCGCGGGCCGCTTGACTGCGCCGCCGCGCTCGATGAAGCTGAACATGGGCATCGACGGGCATTCTGCAGCCGTTCACTCGTGTCGCCACGTAATTCTCGCCGTGCGCGTTAGGGGAAAGCCGATGACAACGACCCAAGCAACTCCGCCACCGGCAGGGGACATCCAGGACGTCGGACCGGCGGCCCTGGTGACCATCCCAACCGGACAGACGGCCTACCTGGTGACCAGGTACCGCGACGCGGTGCACGTGCTGTCCGATCCGGTCTTCAGCCGCCAGGAAGTGTTCCGCACCAGGGGAACCAACTACACCGGTCCGGGCGCGAGCAGCACCGGTGACATGCTGCTCGACATGGACCCGCCGCAGCACACGCGCATCCGCGGCCTGGTGGCCAAGGCGTTCTCCCGCCGCCGCGTCGAGAGCATGCGCCCGGGAGTGCGGCAGATGGTCGACGGTCTGCTCGACGACCTGGCCGAGCAGGGGCCACCGGCGGACCTGGTCGACGCGCTGTGCCTGCCGTTGCCGATCACCGTTGTCTGCCAACTGCTCGGCGTGTCCTACGACGACCGTGGCTGGTTCCAGGAGCGGTCGATGATCCTGGCGTCGACGGCCGACACCGCGGAGACGAAGCTGACCGCGGTGAACGAGCTGCGCGACTACCTGTCGGCGATCATCGCCGACAAACGTAAGTCTCCCAAGGAGGATCTGCTCAGCGAGCTCGTTTCGGCGCGTGCCGACGAGCGGATGTCCGAGGAAGAGCTGATCAACCTCGGTGTGTTGCTGCTGCCCGCCGGATACGAGACGACCGCCAACCAGATGTGCAAGAGCATCCACGCGTTGTTGCTGCGGCCGGAGGAGTACACGGCACTGGCTGCCAACCCGGACGGTGTGCACGCGGCGTCGGAAGAGCTGATGCGGTTGTACCCGTCGGTGCTGACACCCGGATTCCGGGTGCCCACCGAGGACGTCGTCGTCGGCGACGTGCCCATCGCGGCAGGCAGCCTCGTCATCGTGTCCGACGCGCTGGCCAGCCGCGATCCGGAGATCTTCGCACGTGCGCAGGAGATGGACCTCAGGCGCGGCAACAACCCGCATCTGGCGTTCGGCCACGGGCTGCACTTCTGCCTCGGCGCCGCACTGGCCCGCGTCGAACTGGACGTCGCGATAACCGGCCTGGTCACCCGCTTCCCGGGACTGCGGCTCGCCGTCGAGCCCGATACGATCCGCTGGCACACCGAGCGCCGCTTCCGCGGCCCATCGGAACTGCCAGTCACCTGGTGA	MTQTCGRPCAGRLTAPPRSMKLNMGIDGHSAAVHSCRHVILAVRVRGKPMTTTQATPPPAGDIQDVGPAALVTIPTGQTAYLVTRYRDAVHVLSDPVFSRQEVFRTRGTNYTGPGASSTGDMLLDMDPPQHTRIRGLVAKAFSRRRVESMRPGVRQMVDGLLDDLAEQGPPADLVDALCLPLPITVVCQLLGVSYDDRGWFQERSMILASTADTAETKLTAVNELRDYLSAIIADKRKSPKEDLLSELVSARADERMSEEELINLGVLLLPAGYETTANQMCKSIHALLLRPEEYTALAANPDGVHAASEELMRLYPSVLTPGFRVPTEDVVVGDVPIAAGSLVIVSDALASRDPEIFARAQEMDLRRGNNPHLAFGHGLHFCLGAALARVELDVAITGLVTRFPGLRLAVEPDTIRWHTERRFRGPSELPVTW	MWDSLKKSYRHLKNILGFVTDKRNYENIKKLLKNYKILSDISNIIVSVLVFLSGILLIISGIYPSIFYKIKFLDNIYSLSFLRFSHRASILIGLMLIMTSKEVFFKVKRAYYVTLTLLIVGGAFAFIKDLDYKEGIFILGVIILLILSKKSFYRKSIPIKVTKLSGILIVLSIVMIIFASFIHKFNIHFSKNYKYYIDFFHSTKGYLRIALFTYISFIIFVIIWYLTMPKIEDDERYMDADLEKVSKFFKEIDYGTIFSHLVYLKDKKVFWANEGESLIMYSKYKDKIIVLGDPIATKENLYSCIEEFQAFTNLYGYDVVFYEIEEKNFSTYHDAGYYFFKLGEEARIDLEEFNLIGSKKSAFRNTLRRVEREGYNFSIIEPPFNNEVVSQLKEISDKWLGDRKEKGFSLGWFSEDYIQRSPIAILKNEEENKIMGFVTIMDANDGGETVAIDLMRIDKDAPNASMDYLMLNLFLTFKEKGYKYFSLGEAPLSNVGFNTHSHLQEKLARLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYLAYPKFMSLPEVFINLCLLIANSKERVEKK	76.27	gnl|BL_ORD_ID|2110|hsp_num:0	2282		
BGC0000202.1|Azicemicin_9 # 9854 # 11323 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGGAG;rbs_spacer=5bp;gc_cont=0.693	BGC0000202.1|Azicemicin_9 	9854	11323	+	Loose	900	285.419	iri	37.57	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGACACTGCCGTTGTCGTCGTCGGCGCGGGCCCGGCGGGCCTGATGCTGGCAGGCGAGCTGCGGCTCGCCGGTGTGGACGTGGTCGTCGTCGAGAAGCTCCCCGAGCCGTCAGGGGAATCGCGGGGGCTCGGGTTCACCGTGCGCACCATGGAGGTGCTGGACCAACGCGGGCTGCTGCCCCGGTTCGGCGAACTGACCACCACCGCCCATCACCACTTCGGTGGGCTGGCACTGGATCTCAGCGGTCTCGACGGCGCGCACCTGGCCAACAAGTCGGTGTTGCAGTCGCAGACCGAGCAGGTCCTCGAGGAGTGGGCCGTCGAACTTGGCGCGGAGGTTCGCCGCGGCCATGAGCTGCTTTCCCTGACACAGCAAGACAACGGGGTCGAGATCGAGGTGCTCGGCCCGGCCGGGCCCTACCGGCTGCGCTGCGCCTACCTCGTGGGATGCGACGGCGGACGCAGCAAGGTGCGCAAGAGCGTCGGCTTCGACTTCCCCGGCACACCGGCGACCATGGAGATGTTCCTCGCCGACGTGCAGGGCGTTCGGGTACGGGAACGCAAGTTCGGCGAGACGGTGCCCGGCGGCCTGGTCATGGCCGGACACCTGGAGGACGACCTGGTCCGGTTGATCATCTGCGAACATGGAAGCACCCCCAGGAATCGCACCGCCCCGGCCACGTTCGACGAGATCGCGGCGGCGTGGCAGAGGCTGACCGGTGAGGACATCTCGGGTGGCACGCCCGTGTGGACCAGTTCGTACGGCGACGCTGTCCGGCAGGTGACCCACTACCGCATGGGCCGGGTCCTGCTCGCCGGGGACGCGGCGCACATCCACCTGCCCGCCGGTGGCCAGGGCATGAACGTCAGCATCCAGGACTCGGTGAACCTGGGCTGGAAGCTGGGTGCCGTGGCACGCGGCAGCGCCCCGGACGGCCTGCTCGACAGCTACCACACCGAACGGCACCCGGTGGGGCAACAGCTGTTATCCAACACCAGGGCGCAGGGCATCCTGTTCCTGGGTGGTTTCGAGGTCCAGCCGTTGCGGGACCTGATCTCCGAGCTGATCGGGTTCGACAGCGTAAGCCTGCACCTGTCGCGCATGGTCAGCGGCCTGGACATCCGCTACGACGTCGGCGAGGACGACCATCCGCTGGTTGGCCGCCGGATGCCGCACGTCGACCTGGTCGACTACGACCGCAAGACCAGCACCACCGAGTTGCTGCACCCGGGGCGCGGTGTGGTGCTGGACTGCGCCGACGACACCGGTCTGCGCGCGGCCGCCGAGCCGTGGGCCGATCGGGTCGACATCGTCACAGCGCCGCCGCTGGACGACGGCGTGAACGCCCCGTTCTACGGCGCGAGCTCGTTCCTGATCCGACCAGACGGCCACGTCGCGTGGACGTCCGGCGGCAGATCGAGCATCGCGGCGGCCTTGGAACGCTGGTTCGGACCAGCAGCGCCCTGA	MDTAVVVVGAGPAGLMLAGELRLAGVDVVVVEKLPEPSGESRGLGFTVRTMEVLDQRGLLPRFGELTTTAHHHFGGLALDLSGLDGAHLANKSVLQSQTEQVLEEWAVELGAEVRRGHELLSLTQQDNGVEIEVLGPAGPYRLRCAYLVGCDGGRSKVRKSVGFDFPGTPATMEMFLADVQGVRVRERKFGETVPGGLVMAGHLEDDLVRLIICEHGSTPRNRTAPATFDEIAAAWQRLTGEDISGGTPVWTSSYGDAVRQVTHYRMGRVLLAGDAAHIHLPAGGQGMNVSIQDSVNLGWKLGAVARGSAPDGLLDSYHTERHPVGQQLLSNTRAQGILFLGGFEVQPLRDLISELIGFDSVSLHLSRMVSGLDIRYDVGEDDHPLVGRRMPHVDLVDYDRKTSTTELLHPGRGVVLDCADDTGLRAAAEPWADRVDIVTAPPLDDGVNAPFYGASSFLIRPDGHVAWTSGGRSSIAAALERWFGPAAP	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	102.09	gnl|BL_ORD_ID|750|hsp_num:0	796		
BGC0000202.1|Azicemicin_10 # 11388 # 12716 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.728	BGC0000202.1|Azicemicin_10 	11388	12716	-	Loose	900	89.7373	lmrB	28.53	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGAACGCAGCCGTTGGGGACTGGTCGTCGCCGCCGGACTCGCCGTGTTCGTCGCCCAGTTGGACGCCACGATCGTGAACATCGCGCTGCCGTCCATCGAGGACGACCTCGACACGACCACCGCGGCCGTGCAATGGGTCGTGCTCGGCTACCTGACGCCGATCATCGGGCTCGGCCTGTGCGCGGGACGGTGGGTGGACGCGGTCGACCCGCGCCGGGCGCTGGCGCTGACGTGCACGGGATTCGCGCTGTCCACGGCGGCGGCCGGGCTGGCCCCCGGGATCGGCTGGCTGGTGGCGGCCAGGGTGCTGCAGGGCACGTTCGGCGCTGTGCTGCTCGCGCTCTCGTCGGTGCTCGCCACCGTGTCGGTCCGGCCGGACGCGCGGGCGCGGGCGTTCGGGGTGATCATGCTGTTCGGCACCACCGGCGGGGTGACCGGGCCGGTGGTCGGCGGGCAGATCGTGGAGTCGCTCGGCTGGCCGTGGATCTTCTACCTGTCCATCCCGCCGCTGGCGGTGGTCGCGCTGCTCGCCGCGGCGCAACTCCCGCTGGGGGAGCGGCTGACCTGGCCGCGACGCCGGTGGCTCGTGGAAGCGGCCACGTTCGGCGGCGGGGCGGTCGCCGTCCTGTTCGGACTGTCCCTCGCGGTCACCGAGAGTCCTGTGTGGATGATCGTGTCGGTGGTGGCGGTCCCGCTGATCGTGACGTGGTACCGGGGCGCGGACGCGGTGCCGGTGCGCGAACTGCTGGCAACCAGGGGCGTGCTCGGCCCACATGTGGCTCTCGCCTTGGTGTACGTGGGAATCCACGTCCTGATCCTGGTACTGCCGTTCGTCCTGCAGCACGGAATGGGAACCTCGCCCGGCACCGCGGGACTGGTGTTGCTGGCGTACCCGGTCGCGGCGCTGGCGACCAGCTACGGCGCGGGCATGCTCGCCGACCGTGTCGGCACGCGGCCGGTCGCGGTGGCGGGCGCCGCGGTGATCACCGTGGGATTCGTCCTGGTGCTGCTGCCCAACTCCGGTCCGGCGGACCTGTTCTGGCGGCTGGCCGTGGTGGGCGCCGGGTTCGGGATGTTCAACGGGCAGCTGCAGGTGTTCCTGATGGGCAACGTCCCCAGGGCCAGGCTGGGTCTGACCGCGGCGACCTCGAGTTTGGTGCGCCAGTTGGGCAACGCGTTCGGTTCGGCGGCCGGTGCCGCGCTCTGGGCGGTGTCGGGCTCGTCGGCGTTGCGGTGGGCCGCGGCGCTCGCGGCGGTGTCCATGGTGTGTGCCGGGCTGATCGTGGCGCGCACCCGCACGGGGGCCGCAGTCGAGGCGCAGCCGTAG	MERSRWGLVVAAGLAVFVAQLDATIVNIALPSIEDDLDTTTAAVQWVVLGYLTPIIGLGLCAGRWVDAVDPRRALALTCTGFALSTAAAGLAPGIGWLVAARVLQGTFGAVLLALSSVLATVSVRPDARARAFGVIMLFGTTGGVTGPVVGGQIVESLGWPWIFYLSIPPLAVVALLAAAQLPLGERLTWPRRRWLVEAATFGGGAVAVLFGLSLAVTESPVWMIVSVVAVPLIVTWYRGADAVPVRELLATRGVLGPHVALALVYVGIHVLILVLPFVLQHGMGTSPGTAGLVLLAYPVAALATSYGAGMLADRVGTRPVAVAGAAVITVGFVLVLLPNSGPADLFWRLAVVGAGFGMFNGQLQVFLMGNVPRARLGLTAATSSLVRQLGNAFGSAAGAALWAVSGSSALRWAAALAAVSMVCAGLIVARTRTGAAVEAQP	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	92.66	gnl|BL_ORD_ID|554|hsp_num:0	592		
BGC0000202.1|Azicemicin_11 # 12755 # 13165 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.686	BGC0000202.1|Azicemicin_11 	12755	13165	-	Loose	400	24.6386	ErmR	52.38	3000594	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCCAGCCAACGCTTTCACCGACGCCGAACTCGACTACCTCACCGGACAGCCCATCGGCCGTCTGGCCACCGCGCACCTCATCGGAACGCTCCAGGTCAAACCGGTCACCTATCGCTACAACAGCGCCACCGGCACGATCGACATCGGTGGCCGCCGGATGGGCACCAGCCAGAAGTTCCGCAACGTCGCCGCCAACGGACTGGTCGGGTTCGTGGTCGACGACCTGGTGTCCCCCGAACACTGGCAGGTGCGCTGCCTGGAGGTCCGCGGCCACGCGGAGGCCATCACCGACCCGGTCGACTCGGCGTGGGCGGGCGCGGACGTCGGCTACGACGGGGCGATCATCCGGATCCACCCCCGGCGCGTACTCAGCTTCGGCATCGCCGAGGTCGCCGACAAGACCGGCTGA	MPANAFTDAELDYLTGQPIGRLATAHLIGTLQVKPVTYRYNSATGTIDIGGRRMGTSQKFRNVAANGLVGFVVDDLVSPEHWQVRCLEVRGHAEAITDPVDSAWAGADVGYDGAIIRIHPRRVLSFGIAEVADKTG	MAGPQDRPRGRGPSSGRPQRPVGGRSQRDRDRRVLGQNFLRDPATIRRIADAADVDPDGLVVEAGPGEGLLTRELARRAGRVRTYELDQRLARRLSTDLAQETSIEVVHADFLTAPHPEEPFQFVGAIPYGITSAIVDWCLTAPTLTSATLVTQQEFARKRTGDYGRWTALTVTTWPTFEWQYVAKVDRTLFTPVPRVHSAIMRLRRRPQPLLRDAAARSRFADMVEIGFVGKGGSLYRSLTREWPRSKVDSAFARADVHHDEIVAFVHPDQWITLFQLLDGSRGGAARGPGDQRGRRGRPGGGPRPDGRAGGGPRRDAGGRRTGDGRGGRPRPPRGGQA	40.00	gnl|BL_ORD_ID|1513|hsp_num:0	1612		
BGC0000202.1|Azicemicin_12 # 13203 # 13652 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.667	BGC0000202.1|Azicemicin_12 	13203	13652	-	Loose	875	23.8682	mdtP	28.57	3003550	protein homolog model	n/a	n/a	nucleoside antibiotic; acridine dye	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGAACACATTCACGACCGAACACGACACGCTGCTGCGTCGGCTGTCGGACCGAGCCGAGATCTCCGAACTGCTCTCCCTGAACTGGCGCGCGCTCGACGCGCAGGATTTCGACAACGCCGACGAGATGTACACCGACGACATCGAGCTGGTCGTCGGCGGCGGGGAACCGATCACCGGGCTGGCCGAGGTCGTCAGGATCACCCGCGAGCTGAACGTCCACTACGAGTCCACTCAGCACAACGGGTCCAGCCTCGGCATCGAACTGGACGGCGACCGCGCCGTGGTGACGGCCAACGTGATCGGCGTGCTGATCGGCCGTGCGAACGAGGCTCCGCCGGTCAGCGTGAACGTCACCGGTGCCCGGGTTGGCGTGGTGCGCACCGAACGCGGCTGGCGGATGGACCGCATCGAGCTGACGCCGCGCTACCGCTACCCAGTCGGCTGA	MTNTFTTEHDTLLRRLSDRAEISELLSLNWRALDAQDFDNADEMYTDDIELVVGGGEPITGLAEVVRITRELNVHYESTQHNGSSLGIELDGDRAVVTANVIGVLIGRANEAPPVSVNVTGARVGVVRTERGWRMDRIELTPRYRYPVG	MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQWWKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVSANGFLSPYSMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETAAVELSLATGVAQLYYSMQASYQMLDLLEQTHDVIDYAVKAHQSKVAHGLEAQVPFHGARAQILAVDKQIVAVKGQITETRESLRALIGAGASDMPEIRPVALPQVQTGIPATLSYELLARRPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLHTLFKKTSRQFNFIPGLKLPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVEATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQAGPVVEKK	30.53	gnl|BL_ORD_ID|36|hsp_num:0	45		
BGC0000202.1|Azicemicin_13 # 14509 # 15198 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGGGA;rbs_spacer=8bp;gc_cont=0.700	BGC0000202.1|Azicemicin_13 	14509	15198	+	Loose	410	134.035	arlR	35.84	3000838	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; acridine dye	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAATCGCTTCGGATTCTGCTCGTCGAGGACCAGGACAAGGCCAGCTCGCTGCCGCACACCCTGTCGCGGCACGGCTACGACATCGCCACCGTGGGGACCGGCGGCGAGGCGTTGACGTCCAACGACGACGCCGACCTGATCCTGCTCGACCTGGAACTGCCCGACATGGACGGCCTTGAGGTGTGCCGCCAGATCCGGCGGCTCAACGACACGCCGATGATCGCGTTCACCGACGGCGGCGCGAAGCTGGAGCGGGTCCTCGTCCTCCAGGCCGGGTCGGACGACTGCATGGACAAACCGTACGAGTTCCGCGAGCTGCTGGCCAGGATCGAGGCGCTGATGCGGCGGCTGCGGCCGCGGCAGCGCACCCGCGCCGTCGAGCTCAGCCTGTCCATCGGGGCGTTGGAGATCGACGCGACCGCCCGTGAGGCCCGGCTCGACGGCAGGCACGTCGAGCTGACCCGCAAGGAGTTCGAGCTGCTGTACTACCTGGCGCGCAACGCGGGCACCGTCGTCACGCGCCAGCGGCTGATGGCCGAGGTGTGGGGCGACCAGACCCCGCACGCGGCGAGCGTGCGCGCGAGCCGGACCATCGACACCCACGTCGGCTCGCTGCGCAGCAAACTCGGCGGCAGCGGCTGGATTCGCACCGTTCGCGGCGTCGGATTCCGTTTCGCCTGCCGCTGA	MQSLRILLVEDQDKASSLPHTLSRHGYDIATVGTGGEALTSNDDADLILLDLELPDMDGLEVCRQIRRLNDTPMIAFTDGGAKLERVLVLQAGSDDCMDKPYEFRELLARIEALMRRLRPRQRTRAVELSLSIGALEIDATAREARLDGRHVELTRKEFELLYYLARNAGTVVTRQRLMAEVWGDQTPHAASVRASRTIDTHVGSLRSKLGGSGWIRTVRGVGFRFACR	MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSINGLEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQPQKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYNSEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR	104.57	gnl|BL_ORD_ID|1306|hsp_num:0	1390		
BGC0000202.1|Azicemicin_14 # 15446 # 16957 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGGGA;rbs_spacer=10bp;gc_cont=0.698	BGC0000202.1|Azicemicin_14 	15446	16957	+	Loose	900	299.671	iri	40.57	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGTCAATGGGAAGCCCGTTGACGCTCCCGTGATCGTCGTCGGCGCCGGGCCGTCCGGCCTGATGCTCGCCGCCGAACTGCGGCTCGGTGGAGCCGACGTCATAGTCCTTGAGCGGCTCGCCGAGCGGACCGGGGAATCCCGTGGGCTTGGGCTGTTCATCCGCACGATGGAGGTGTTCGACCAGCGCGGCCTGCTGCCCCGGTTCGGCGATCCGGAACAGAGCTCGCTCGGCCACTTCGGTGGCGTGCCACTGGACTTCAGCGTGCTCGACAACCCGCACCTGGCCAACCGCACGGTGCCGCAGTCACAGACCGAGACCGTGCTGGAGGAGTGGGCGGCCGAACTGGGCGCGGACATCCGGCGCGGCCACACGGTCCGCGCGATCCGGCCGGACGCCGACGGTGTGGACGTCGAGGTGGCCGACGCGGACGGCACCGTCCGGACACTGCGCTGCCAGTACCTGGTCGGTTGCGACGGCGGACGCAGTGTGGTCCGCAAGCAGTGTGGCTTCGACTTCCCCGGTGTCGCGGGCACGATGGAGATGTTCCAGGTCGACCTCAAGGGCATCGAGATGAAGCCGAGGGAGATCGGCGAGAAGGTCGCCGGCGGAATGGTGATGGGCGGACCGCTGGAGGACGGCGTCTTCCGGATCACCATCTGCGAGCGGGACAACCTGCCGAAGGAACGCACCGAACCGGTCACGTTCGCCGAGACCGTGGCGGCGTGGAAACGCCTGACCGGTGAGGACATCTCGGCCGCCACCCCGGTCTGGATCGGCGCGTTCACCGACTCGACAAGGCTGATCACCGAGTACCGCCGCGGCCGCGTGCTGCTGGCGGGCGACGCGGCGCACATCCACCTGCCCGCGGGCGGCCAGGGCATGAACACCAGCATCCAGGACTCGGTGAACCTCGGCTGGAAACTGGCCGCGGTGGTCCGCGGCACCAGCCCGGACAGCCTGCTGGACACCTACCACACCGAACGCCACCCAGTCGGCGAGCGGCTGACCATGAACACCCGTGCCCAGGCGCTGTTGTTCCTGCGTGGCCAGGAGATGATGCCGCTGCGCCAGGTGATGACCGAACTGGTCGAGTACCCGGAGGTGCACCGGCACCTGGCCCGCATGGTCAGCGGCCTTGCCGTGCGCTACGACGTCGGCGAGGGCACGCACCCGCTGCTGGGTGAGCGGATGCCGCTGGTCGAACTGATCACCGCGGACGGCAAGACGACCACGACCGAACTGCTGCGCCCGGCCCGTGGCGTGCTGATCGACTGCGCGGACAACGCCTCGCTGCGCGAGACAGCGCGGGCGTGGGGAGACCGCGTGGACGTGATCACCGCGTCACCGCACGACAGCGGCCCGCTGGACGGCACCGCGGCGGTGTTGCTGCGGCCGGACGGGCACGTGGCGTGGACGCCCGGGAGCAGCGACGACCTGGCGACCGCGCTGGAGCGCTGGTTCGGCCCAGGCCAGTTGTCATCGGGCCGCGAAGTGAAGGAATCACCATGA	MVNGKPVDAPVIVVGAGPSGLMLAAELRLGGADVIVLERLAERTGESRGLGLFIRTMEVFDQRGLLPRFGDPEQSSLGHFGGVPLDFSVLDNPHLANRTVPQSQTETVLEEWAAELGADIRRGHTVRAIRPDADGVDVEVADADGTVRTLRCQYLVGCDGGRSVVRKQCGFDFPGVAGTMEMFQVDLKGIEMKPREIGEKVAGGMVMGGPLEDGVFRITICERDNLPKERTEPVTFAETVAAWKRLTGEDISAATPVWIGAFTDSTRLITEYRRGRVLLAGDAAHIHLPAGGQGMNTSIQDSVNLGWKLAAVVRGTSPDSLLDTYHTERHPVGERLTMNTRAQALLFLRGQEMMPLRQVMTELVEYPEVHRHLARMVSGLAVRYDVGEGTHPLLGERMPLVELITADGKTTTTELLRPARGVLIDCADNASLRETARAWGDRVDVITASPHDSGPLDGTAAVLLRPDGHVAWTPGSSDDLATALERWFGPGQLSSGREVKESP	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	105.01	gnl|BL_ORD_ID|750|hsp_num:0	796		
BGC0000202.1|Azicemicin_15 # 16954 # 18222 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.693	BGC0000202.1|Azicemicin_15 	16954	18222	+	Loose	750	201.445	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.54	3003463	protein variant model	F413L	n/a	isoniazid	antibiotic target alteration	antibiotic resistant kasA	ATGAGCCGCAGGGAAGTGGCGATCACCGGGATCGGGGTCATCTCCCCCGGCGGGATCGGCGTGCCGGAGTTCTGGTCGTTGCTGACCGAGGGCCGCACGGCCACCAGGCTGGTCACGTCGTTCGACCCGGCGCAGTTCCGGTCCCGGATCGCCGCGGAGGCCGACTTCGACCCGGCCGAGCACGGCCTCGGCCCGCAGGAGATCCGGCGGATGGACCGGGCCGCCCAGTTCGGCGTGGTGACCGCGCGGGAGGCGTTGAGCCGCAGCGGACTCGACATGTCCACTGTGGATCCGGGCAGGGTCGCGGTGAGCGTCGGCAGTGCGATCGGCGCGTCCATCGGACTGGAGGAGGAGTACCGGGTCGCCAGCGACGACGGCAAACTCGACCTGCTCGACGAGAACTACGCGTCCAAACACCTCTACAACTACTTCGTGCCGAGCTCGATCGTGGCCGAGGTGGCGTGGGCGGTCGGCGCGGAAGGCCACGCCACCATGGTCTCCGACGGCTGCACGTCCGGTGTGGACGCTGTCGGCTACGGCTGCGAACTGATCCGCGAGGGCTCGGCCGACGTGGTGTTCGCGGGCGGCACCGACGCCCCGATCACGCCGATCACCCTGGCCTGCTTCGACGCGATCAAGGCGACCAGCCCACGCAACGACGACCCGGAGCACGCCTCCCGGCCGTTCGACGCCAGCCGCAACGGATTCGTGCTCGGTGAAGGCGCCGCGATGTTCGTGCTGGAGGAACTGGAGCACGCCCGCAGCCGTGGCGCGCACATCCACGCGATCGTCTCCGGCTTCGCCGGGCGCTGCAACGCCTATCACATGACGGGCCTGAAAGCCGACGGCCGCGAGATGGCCGAGGCGATCCGGGTCGCGATGGACGAGGCCAAGGTCAACGCCGAGGACATCCAGTACGTCAACGCGCACGGCTCGGGCACCAAGCAGAACGACCGGCACGAGACCGCCGCGTTCAAACGCAGCCTCGGCGAGCAGGCGTACCGGATCCCGGTCAGTTCGATCAAGTCGATGATCGGGCACTCGCTCGGTGCGATCGGTGCGATCGAGGTGGCCGCGTCCGTGCTGGCACTGGAACACGACGTGCTGCCGCCGACGGCCAACCTGCACACGCCCGATCCCGAGTGCGACCTGGACTACATCCCGGTCACCGCACGTGAGCAGGACACCGACACGGTCCTGACCGTCGCCAGCGGGTTCGGCGGGTTCCAGAGCGCGATGGTGCTCACCGCACCGGGAGTGAGCCGATGA	MSRREVAITGIGVISPGGIGVPEFWSLLTEGRTATRLVTSFDPAQFRSRIAAEADFDPAEHGLGPQEIRRMDRAAQFGVVTAREALSRSGLDMSTVDPGRVAVSVGSAIGASIGLEEEYRVASDDGKLDLLDENYASKHLYNYFVPSSIVAEVAWAVGAEGHATMVSDGCTSGVDAVGYGCELIREGSADVVFAGGTDAPITPITLACFDAIKATSPRNDDPEHASRPFDASRNGFVLGEGAAMFVLEELEHARSRGAHIHAIVSGFAGRCNAYHMTGLKADGREMAEAIRVAMDEAKVNAEDIQYVNAHGSGTKQNDRHETAAFKRSLGEQAYRIPVSSIKSMIGHSLGAIGAIEVAASVLALEHDVLPPTANLHTPDPECDLDYIPVTAREQDTDTVLTVASGFGGFQSAMVLTAPGVSR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.44	gnl|BL_ORD_ID|2018|hsp_num:0	1943		
BGC0000202.1|Azicemicin_16 # 18219 # 19430 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.708	BGC0000202.1|Azicemicin_16 	18219	19430	+	Loose	680	33.8834	LpeA	25.75	3004099	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAACCGTCCACAGTAGTCACCGGGATCGGTGTCACAGCGCCGAACGGACTTGGCACCAAGGCGTACTGGGCCGCGACCCTGGAGGGCACGAGCGGCATCGACCGCGTCACCCGTTTCGACCCGAGCCGCTACCCCGCCCAACTGGCCGGTGAGGTTCCGGGATTCGTGGCCAAGGAGCACCTGTCCAGCAGACTGCTGCCGCAGACCGACCACATGACGCGCCTCGCGCTGGTGGCCGCCGACTGGGCGTTCGCCGACGCGGGCGTCGTGCCCGACCAGCTCGACGGCTACGACATGAGCGTGGTGACCGCCAGCTCGGCCGGTGGCTTCGAGTTCGGTGAACGCGAGCTGCAGGCGTTGTGGAGCAAGGGAAGCAAGTACGTCAGCGCCTATCAGTCGTTCGCGTGGTTCTACGCGGTGAACACCGGGCAGATCTCGATCCGCAACGGCATGCAGGGCCCGAGTGCCGCGCTGGTCAGCGACCACGCGGGCGGTCTGGACGCGATCGGCCAGGCGCGGCGGCAGATCCGCAGGGGCACGCCGCTGGCGCTGTCCGGTGGTGTGGACGGCTCGATCTCCTCCTACGGCTGGATCTCGCACCTGGCCAGCGGGCGGATCAGCACGGCCGCCGAGCCGGACCGGGCGTACCTGCCTTTCGACGCGGCCGCGTCCGGCTACGTCCCCGGTGAGGGCGGCGCGTTGTTGGTACTGGAGGAGGCGACGGCCGCGCGCCGACGCGGGGCTGAGGTCTACGGCGAGATCGCCGGATACGCGTCCACGTTCGACCCCCAGCCGGACACAGGGCGGCCACCGGCGCTCAAACGGGCGATCACGCTGGCGCTCGACGACGCTGGCCTGTCCCCCGCCGACATCGACGTGGTGTTCGCCGACGCGGTCGCCGTCCCGGAGCTCGACCGGCTGGAAGCCGAGGCGATCACCGAGGTGTTCGGCCCGCGCGGTGTGCCGGTCACCGCGCCGAAGACCATGACCGGACGGCTGTACGCGGGCGCGGCCCCGCTGGACGTGGCCGCCGCGTTGCTCGCCATCCGCGACAGCGTGATCCCGCCGACCGTCCACATCGAACCGGACCGGGGCTACCAGCTGGACGTGGTGACCGGGCCCCGGACAAGGCCGTTGCACAGCGCTCTCGTGATCGCCCGTGGCTACGGCGGTTTCAACTCGGCCGTCGTCGTGCGGTCTGCTCGCTAG	MKPSTVVTGIGVTAPNGLGTKAYWAATLEGTSGIDRVTRFDPSRYPAQLAGEVPGFVAKEHLSSRLLPQTDHMTRLALVAADWAFADAGVVPDQLDGYDMSVVTASSAGGFEFGERELQALWSKGSKYVSAYQSFAWFYAVNTGQISIRNGMQGPSAALVSDHAGGLDAIGQARRQIRRGTPLALSGGVDGSISSYGWISHLASGRISTAAEPDRAYLPFDAAASGYVPGEGGALLVLEEATAARRRGAEVYGEIAGYASTFDPQPDTGRPPALKRAITLALDDAGLSPADIDVVFADAVAVPELDRLEAEAITEVFGPRGVPVTAPKTMTGRLYAGAAPLDVAAALLAIRDSVIPPTVHIEPDRGYQLDVVTGPRTRPLHSALVIARGYGGFNSAVVVRSAR	MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSHNLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS	113.52	gnl|BL_ORD_ID|2453|hsp_num:0	2758		
BGC0000202.1|Azicemicin_17 # 19439 # 19699 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.628	BGC0000202.1|Azicemicin_17 	19439	19699	+	Loose	500	24.2534	SCO-1	42.86	3004856	protein homolog model	n/a	n/a	cephalosporin; penam; penem	antibiotic inactivation	SCO beta-lactamase	ATGTCGGACAAGTTCACCATCGAGGACCTCAAGTCGATCCTGCGCGAGTGCGCGGGTGAAGACGAGGGCGTCGACCTGGACTCGCAGATCCTGGACACCCAGTTCGAGGATCTCGGCTACGAGTCGTTGGCCATTTTCGAGACCACCAGCCGGATCGAACGTGAGTACGGCATCTCGCTCGGTGAGGACGCCCTCAACGACGCCAACACCCCGCGTGCCCTGCTCGACATCGTCAACGCACGCCTGCTCAGCCCGGCCTGA	MSDKFTIEDLKSILRECAGEDEGVDLDSQILDTQFEDLGYESLAIFETTSRIEREYGISLGEDALNDANTPRALLDIVNARLLSPA	MTRSALLIPLTTAAIALNAISPVYASDTHSIDDTVKQVETTLGAKVGIAVLDTGSQRAWFHRADDRFPMASTSKALTCAALLDKGQSFMNKEALIKKADLDEYAPVTSGIVGKKVSAADLCSITMRTSDNTAVNKVLEILGGPQAVTAYLRKTGDNITRLDRNEPDLNEGTPGDVRDTTTPRAILETLNKLVLGPTLGSDERKQLTTWLESNEVGDPLLRAGVPSDWRVADRTGAGGNGTRGVIAVMWPPKHAPIIAAIYITQTKATMEERNAAIASIGKAIAAEVLE	29.86	gnl|BL_ORD_ID|2690|hsp_num:0	3653		
BGC0000202.1|Azicemicin_18 # 19721 # 20494 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.695	BGC0000202.1|Azicemicin_18 	19721	20494	+	Loose	750	27.7202	mdtH	26.26	3001216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCGAAAGTAGCCCTCGTCACCGGCGCGACCAGCGGTATCGGCCTCGCGGTGGCCCGTGCCCTCGCCGGGCTCGGCCACCAGGTCTTCATCGGGGCGCGGACCGCCGACAACGTCGCCGCGACCGTGAAGTCCCTGCAGAAGGAAGGCTTCGACGTCGACGGCACCAGCCTCGACGTGCGCGAGGCCGGTGATGTCCGCGGTTTCGTGCAGGCGGCCGTCGACCGCTACGGCCCGGTGGACATCCTGGTCAACAACGCGGGCCGGACCGGCGGCGGCACCACCGCCGACATCCCGGACGACCTGTGGCACGACGTCATCGCCACCAACCTCAACAGCGTCTTCCTGATGACCAGGGAGGTGCTCACCACCGGCGGCATGCGGGAGAAGGCCACCGGCCGGATCGTCAACATCGCCTCCACGGCGGGCAAACAGGGCGTGGTACTCGGTGCGCCGTACTCGGCGTCCAAGCACGGCGTCGTCGGCTTCACCAAGGCACTGGGCAACGAGCTCGCCCCGACCGGCATCACCGTGAACGCGGTCTGCCCCGGCTACGTCGAGACGCCGATGGCGCAGGGCGTCCGGCAGCGCTACGCGGTGGCGTACCAGACCACCGAGGACGCCATCCTGCAGAAGTTCAACGCCAAGATCCCGCTCGGCCGGTACTCCACGCCCGAGGAGGTCGCCGGTCTGGTCGGCTACCTGGTCTCGGACACCGCCGCGTCCATCACCTCGCAGGCGCTCAACGTCTGCGGCGGCCTCGGCAACTTCTAA	MPKVALVTGATSGIGLAVARALAGLGHQVFIGARTADNVAATVKSLQKEGFDVDGTSLDVREAGDVRGFVQAAVDRYGPVDILVNNAGRTGGGTTADIPDDLWHDVIATNLNSVFLMTREVLTTGGMREKATGRIVNIASTAGKQGVVLGAPYSASKHGVVGFTKALGNELAPTGITVNAVCPGYVETPMAQGVRQRYAVAYQTTEDAILQKFNAKIPLGRYSTPEEVAGLVGYLVSDTAASITSQALNVCGGLGNF	MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA	63.93	gnl|BL_ORD_ID|349|hsp_num:0	375		
BGC0000202.1|Azicemicin_19 # 20506 # 21456 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.670	BGC0000202.1|Azicemicin_19 	20506	21456	+	Loose	1800	31.187	mdtC	32.76	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTCGAACAAGAACCTGCGCGAGGTCGAGCACGAGATCACCGTGCGGGCCGGTGCCGACGAGGTGTACCGGCTGCTGGCCGAGTGCGTGAACTGGCCCCGGCTGTTCCCGCCGACGGTGTACGTAGACCGGACCGGGATCTCGGCCGAGGAGGAGCGGATCCGGATCTGGGCGACCGCCAACGGCGAGGCGAAGAACTGGACCTCCCGCCGCTGGCTCAAGCCCGCCGAGCGGCGGATCGACTTCCGCCAGGAGGTGTCGCCGCCGCCGGTGGCGTCCATGGGCGGCGGTTGGATCATCGAACCGCTGTCGGCGGACGAGAGCCGAGTGCGGCTGCTGCACGACTACCGGGCGATCGACGACGACCCGGAGAGTCTGAAGTGGATTGACGAGGCGGTGGACACCAACAGCCGCAAGGAACTCGGCGCGTTGAAGGAGAACATCGAACGGGCGGCGGTGACGGCACACGAGGGCCTGATGCTGTCGTTCGTCGACACGGTGGAGATCGCGGGCTCGGCCAAGGACGTGTACGAGTTCGTCAACGAGGCCGACAAGTGGACCGAGCGGCTGCCGCACGTGGCCAGGGTGTCGCTGCAGGAGGACACCCCGGGCCTGCAGGTACTGGAGATGGACACCCGCACCAAGGACGGCTCGACGCACACGACGAAGTCGGTCCGGGTCTGCTTCCCGAACGAGAAGATCGTGTACAAGCAGACCACGCTGCCCGCGCTGATGGCGTTGCACACCGGGTACTGGGAGTTCGTCGAGCACGACAACGGCGTGACCGCGTCCTCCGAGCACACCGTCGTGATCAACACCGAGAACGTCGCCAAGATCCTCGGTGCCGACGCGACCGTGGCCGACGCCAAGAAGTTCGTGCGCAACGCCCTGAGCACCAACAGCCGCGCGACTCTCGGGCACGCCAAGGACTACGCCGAGAAGCGGAGTTGA	MSNKNLREVEHEITVRAGADEVYRLLAECVNWPRLFPPTVYVDRTGISAEEERIRIWATANGEAKNWTSRRWLKPAERRIDFRQEVSPPPVASMGGGWIIEPLSADESRVRLLHDYRAIDDDPESLKWIDEAVDTNSRKELGALKENIERAAVTAHEGLMLSFVDTVEIAGSAKDVYEFVNEADKWTERLPHVARVSLQEDTPGLQVLEMDTRTKDGSTHTTKSVRVCFPNEKIVYKQTTLPALMALHTGYWEFVEHDNGVTASSEHTVVINTENVAKILGADATVADAKKFVRNALSTNSRATLGHAKDYAEKRS	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	30.83	gnl|BL_ORD_ID|1241|hsp_num:0	1315		
BGC0000202.1|Azicemicin_20 # 21463 # 22818 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.700	BGC0000202.1|Azicemicin_20 	21463	22818	+	Loose	900	233.802	iri	37.27	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGCGGGACACGTCCGTCATCGTGGTCGGCGCGGGCCCTGCGGGCCTGCTGCTGGCCGGTGAGCTGCGGCTCGGCGGAGCCGACGTGATCGTGCTGGAACGGCTGGCCGAACCGGTCACCGAGTCACGGGCCTCCGTGCTGCACGCCCGCACGATGGAACAGTTCGACCAGCGGGGCCTGCTCGACGAACTGGGCACGCTGCCGAACCTGCCGATGGGCCACTTCGGCGGGATCCCGCTCGACCTGACGGCCGACACGCGGTACCCGGGGCAGTGGAAGCTGCTCCAGACCCGCACCGAGGCGCTGCTTGAGCGCTGGGCCACCGGGCTCGGCGCTCGGGTGCGCCGCGGCTTCGAGGTCACCGGGCTGACCGAGAAGTCCGACTGCGTCGAGATATCCGGCGTCGAGGTCACCGGTACGGACGTGCTGCGCGCGGACTACGTGGTCGGCTGCGACGGCGAGGACAGCACCGTCCGGTGGCTCGCCGGGTTCGACTTCCCCGGCGAGGACGCGAGTCGCGAGCTGATCAGGGCCGACATCGTCGGCGTTGAGATCCTGAACCGCAAGTTCGAACGGCATCCGGCGGGGCTGGCGAACGCCTACCGCTACCCGGACGGCGTGACCAGGCTGATGATGCACGAGTTCGGTGCACGCCCCCGTGCCGTCGAGCCGACGTTCGACGAGCTCGTCCGGACATGGCAGCGGATCACCGGTGAGGACATCAGCGGCGGAACACTGGTGTGGCTCAACGCGTTCGACGACACGCGCAGGCAGGTGTCCCAGTACCGCAAGGGCCGGATCCTGCTGGCTGGGGACGCCGCGCACCGGCAGTTGCCGACCGGCGGTCAGGCGCTCAATCTGGCTCTGCAGGACGCCATGAACCTTGGCTGGAAACTCGCCGCGAAGGTGCGCGGCGATGTCGACCTGCTCGACACGTACCACGAGGAACGCCACCCGGTCGGCGCGCACGTGCTGGCCAACATCGCCGCGCAGACGCAGTTGCTGTTCGGCGACCGGAACGTCGAGCCGGTTCGCACCGTGATGACCGAGCTGATGCGGATGGAGCCGGTCCGTGCCCACCTCGCCGAGATGATCAGCGGCCTCGGCATCCGCTACGGCGTGGTCGGCAGCCGAGTCCCGCCGATCCCGGCCCTGCGCACAGGTAAGGGCGTGCTGCTGGGTGGGGACCGGTCCGTCGCCAAGCCGTGGGCCGACCGGGTCGAGTTCGCCGAAGCCCCCGATCAGCTGGGCTTCGACAGCGCACTGGTCCGGCCGGACGGCTACATCGCCTGGGCCGATGGTTCCACGAGCGAACTGAAGGCCGCCCTGCGCCGATGGTTCGGCAACCCACACTGA	MRDTSVIVVGAGPAGLLLAGELRLGGADVIVLERLAEPVTESRASVLHARTMEQFDQRGLLDELGTLPNLPMGHFGGIPLDLTADTRYPGQWKLLQTRTEALLERWATGLGARVRRGFEVTGLTEKSDCVEISGVEVTGTDVLRADYVVGCDGEDSTVRWLAGFDFPGEDASRELIRADIVGVEILNRKFERHPAGLANAYRYPDGVTRLMMHEFGARPRAVEPTFDELVRTWQRITGEDISGGTLVWLNAFDDTRRQVSQYRKGRILLAGDAAHRQLPTGGQALNLALQDAMNLGWKLAAKVRGDVDLLDTYHEERHPVGAHVLANIAAQTQLLFGDRNVEPVRTVMTELMRMEPVRAHLAEMISGLGIRYGVVGSRVPPIPALRTGKGVLLGGDRSVAKPWADRVEFAEAPDQLGFDSALVRPDGYIAWADGSTSELKAALRRWFGNPH	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	94.15	gnl|BL_ORD_ID|750|hsp_num:0	796		
BGC0000202.1|Azicemicin_21 # 22830 # 23579 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.685	BGC0000202.1|Azicemicin_21 	22830	23579	+	Loose	500	25.0238	OXA-96	30.3	3001631	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACAACGGCACTTGTCACCGGAGCCAGCCGTGGCATCGGCCGCGCCATCGCCCGTCGCCTGGCCCGCGACGGCGCTCTGGTCGCCGTGCACTACGCGACCGAGGCCGAGTCCGCCGCCGAGACGGTCCGCGAGATCGAGGCGAACGGCGGACAGGCCTTCGCCGTCCAGGCGAGGTTCGGCGCACCCGGCTACGTCGACGACCTGTTCGACGCCGTCGAGAGCGGGCTGAAGGCACGCACCGGAACGTCCACACTGGACATCCTGGTGAACAACGCCGGGATCAAGTCGGTGCGGGAACCGGAGGAGCTGACACCGCAGGAGCTCGACGACCTGTTCGAGGTCAACGCCAAGGCGCCGTTCCTGATCATCCAGCGCGCGCTCGGCCTGTTGCCGGACGGCGCGCGGATCATCACCCTCTCCTCGGGCATCACCCGATTCGGCAACCCGCAGGAGATCGGGTACGCGATGAGCAAGGGCGCGGTCGAACAGCTGTCCCTGCACTGGGCCAAACACCTGGGGCCACGGGGAATCACCATCAACACCGTGGTTCCCGGCGTCACCGACAACGGCACCGAGCCGGTGTTCCGCGATCCGCAGATCCGTGCGCACCTCTCGGAGATGGCCGCGCTCAAGCGCGTCGGCGAGCCCACCGACATCGCCGACATCGTCGGGTTCCTCGCCAGTACCGACGCCAGGTGGATCACCGGTGCGCTGATCAACGCCAGCGGCGGCGCACTGCTCGACTGA	MTTALVTGASRGIGRAIARRLARDGALVAVHYATEAESAAETVREIEANGGQAFAVQARFGAPGYVDDLFDAVESGLKARTGTSTLDILVNNAGIKSVREPEELTPQELDDLFEVNAKAPFLIIQRALGLLPDGARIITLSSGITRFGNPQEIGYAMSKGAVEQLSLHWAKHLGPRGITINTVVPGVTDNGTEPVFRDPQIRAHLSEMAALKRVGEPTDIADIVGFLASTDARWITGALINASGGALLD	MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQMGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEKADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL	88.93	gnl|BL_ORD_ID|566|hsp_num:0	605		
BGC0000202.1|Azicemicin_22 # 23602 # 25158 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=6bp;gc_cont=0.696	BGC0000202.1|Azicemicin_22 	23602	25158	+	Loose	700	28.4906	ACT-22	30.65	3001843	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGCTGAGCACCACCTCCGAACGGCTGGCCGAACTGGCCGACGTCAAGGACAGGGCCACCGCCGGGACCGATCCGGCAGCGACCGAGCGGCAGCACGCCAAGGGCAAGCTCACCGCCAGGGAGCGGATCGACCTGCTGCTCGACCCCGGCTCGTTCCGCGAGATCGAGCCGTTGCGCCGACACCGGGCGGCCGGTTTCGGGCTGGAGTCGAAACGGCCGTACACCGACGGGGTCGTCACCGGCTGGGGCACGGTGTACGACCGCACGGTCTTCGTCTACGCCCACGACTTCCGGATCTACGGCGGGTCACTCGGCGAGGCGCACGCCACCAAGATCCACAAGATCATGGACATGGCCGAGGCCGCGGGTGCGCCGCTGGTGTCGCTCAACGACGGCGCGGGCGCGCGGATCCAGGAAGGCGTCACCGCGCTGGCCGGGTACGGCGGGATCTTCCAGCGCAACGTCCGCTGCTCCGGGGTGATCCCGCAGATCAGCGTGATGGTCGGGCCGTGTGCCGGTGGCGCCGCCTACTCCCCCGCGCTGACCGACTTCGTGTTCGCGGTGCGGGAGATCTCGCAGATGTTCATCACCGGGCCGGACGTCGTCCACGCGGTGACCGGCGAGCAGGTCACGCACAACGGGCTCGGCGGCGCCGACGTGCACGCGACGTCGTCGGGCGTGGCGCACTTCGCGTACGACAACGAGCAGGAGTGCCTTGAGGACGTTCGCTACCTGATCTCGTTGCTGCCGTCCAACAACCGGGAGCTCCCGCCGCCGGACACGACGGCCGACCCCGCCGACCGGTTGACCGACCGGCTGCTCGACCTGGTGCCGACGAACCCCAACCAGGCCTACGACATCCGCGAGGTGATCGCCGAGGTCGTCGACGACGGCGACTACCTGGAGGTGCACGAGGGCTGGGCGCCGAACATCGTCTGCGCGCTGACCCGGGTCGGTGGGCACGTCGTCGGTGTGGTGGCCAACCAGCCGTCGGCCATGGCCGGTGCGCTGGACATCAGGGCGAGCGAGAAAGGCGCGCGGTTCGTCCAGTTCTGCGACGCCTTCAACATCCCGCTGGTGACGCTGGTGGACGTGCCCGGCTTCCTGCCCGGTGTGGACCAGGAGCACGACGGCATCATCCGGCACGGCGCGAAGCTGCTGTACGCCTACTGCAACGCCACGGTTCCCCGGATCTCCGTGGTGCTGCGCAAGGCGTACGGCGGCGCGTACATCGTGATGGACTCCCGTTCGATCGGCGCGGACCTGGCTTTGGCCTGGCCGACCAACGAGATCGCGGTGATGGGCGCGGACGGCGCGGCGAACGTCATCTTCCGCAAGGAGATCGCGGCGGCGCAGGACGCCGAGGCGGTCCGCCACCAGAAGATCAAGGAGTACCGGACCGAGCTGATGCACCCGTACTACGCGGCGGAGCGCGGCCTGATCGACGACATCATCGACCCGCGGCAGACCAGGGCGGCGCTGATCGACGGGCTGGCGATGTTACGCGCGAAGCACGCGAGCCTGCCCGCCCGCAAGCACGGGAACCCGCCGCAATGA	MLSTTSERLAELADVKDRATAGTDPAATERQHAKGKLTARERIDLLLDPGSFREIEPLRRHRAAGFGLESKRPYTDGVVTGWGTVYDRTVFVYAHDFRIYGGSLGEAHATKIHKIMDMAEAAGAPLVSLNDGAGARIQEGVTALAGYGGIFQRNVRCSGVIPQISVMVGPCAGGAAYSPALTDFVFAVREISQMFITGPDVVHAVTGEQVTHNGLGGADVHATSSGVAHFAYDNEQECLEDVRYLISLLPSNNRELPPPDTTADPADRLTDRLLDLVPTNPNQAYDIREVIAEVVDDGDYLEVHEGWAPNIVCALTRVGGHVVGVVANQPSAMAGALDIRASEKGARFVQFCDAFNIPLVTLVDVPGFLPGVDQEHDGIIRHGAKLLYAYCNATVPRISVVLRKAYGGAYIVMDSRSIGADLALAWPTNEIAVMGADGAANVIFRKEIAAAQDAEAVRHQKIKEYRTELMHPYYAAERGLIDDIIDPRQTRAALIDGLAMLRAKHASLPARKHGNPPQ	MMKKSLCCALLLSTSCAALAAPMSETQLAKVVARTVTPLMKAQSIPGMAVAVIYQGQPHYFTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLSDPVTKYWPELTGKQWQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGALAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVKDMASWVVANMAPDGVQDASLKQGMALAQSRYWRTGSMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKKLGIVMLANKSYPNPARVEAAYRILSALQ	135.96	gnl|BL_ORD_ID|373|hsp_num:0	401		
BGC0000202.1|Azicemicin_23 # 25155 # 25316 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GGGA;rbs_spacer=10bp;gc_cont=0.747	BGC0000202.1|Azicemicin_23 	25155	25316	+	Loose	700	20.7866	DHA-16	44.44	3002147	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	ATGACCGGCATCCGGGTGGTCAGGGGCGATCCCTCGGCCGAGGAGCTGGCCGCTCTGGTCCTGGTGCTGCTCACCCCGCGCCCGCAGGCCGATGCCGGGCCGGTCCGGCGTCCGGCGACCTGGCGGCAGCCGGACCGGACGGCACCTACCTGGAAGGACTGA	MTGIRVVRGDPSAEELAALVLVLLTPRPQADAGPVRRPATWRQPDRTAPTWKD	MKKSLSATLVSALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETSLNDPAVKYQPELTQPQWKGITLLDLATYTAGGLPLQVPEAVKSSEDLLHFYQQWQPSWQPGKMRLYANSSIGLFGALTATAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNNQPVRVTGGPLDAESYGVKSASKDMLRWAEINMSPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	13.98	gnl|BL_ORD_ID|394|hsp_num:0	423		
BGC0000202.1|Azicemicin_24 # 25319 # 25903 # 1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.691	BGC0000202.1|Azicemicin_24 	25319	25903	+	Loose	750	26.9498	tet(55)	31.58	3004591	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGCCGGAGCACCCCTTCAAGCTGGCCGTGGTCATCGGCAGCGTGCCGGGCAGCAGCACCGGTCCGGTCATCGCCCGGTGGTTTCTCGGCGAGGCCGAACAGCGCGACGACATCCGCATCGACGTGGTCGACCTGACCACCGGGCCGCCGCTGAGCATGGCCAGACCGACCTGGCCGCCGGGGACGTCCGATGGGACCGCGCTGGACACGATCACGCCGCGGCTGGCGTCGGCCGATGCCTTCGTGATCGTGACACCGGAGTACAACCGCAGCTTCCCCGCCGTGTTGAAGAACGCGATCGACTGGCATTTCGCCGAATGGCACGCCAAACCGGTCGGCTTCGTCTCCTACGGCGGCCGGTCGGGTGGTCTGCGCGCGGTCGAGCAGCTCCGGCTGGTGTTCGGCGAGCTGCACGCGGTGCCGATCCGGGACATCGTCAGCTTCCACGGGCCCTGCTTCGACGAGCACGGCAGGCCGTACGACCGCGAGGGATGCGACGCGGCCGCCAAGAACATGCTCGACCAGCTCTCCTGGTGGGCGACGGCACTACGCGAAGCACGAGCCAAACGCCCGTACCAGACCTGA	MPEHPFKLAVVIGSVPGSSTGPVIARWFLGEAEQRDDIRIDVVDLTTGPPLSMARPTWPPGTSDGTALDTITPRLASADAFVIVTPEYNRSFPAVLKNAIDWHFAEWHAKPVGFVSYGGRSGGLRAVEQLRLVFGELHAVPIRDIVSFHGPCFDEHGRPYDREGCDAAAKNMLDQLSWWATALREARAKRPYQT	MPHTKKILVIGASIAGPALCYWLNHYGFQPTLVEKNQSTRKGGYAIDLRGIAVDVAKQMGIYDSVCAMRTSLQCVRYVDAAGNLLFEEHGEKGGFRQGDEVEIVRGDLVDILMKTITDIPCFYDHAIESLTQHDDHVTVQFKNGKTENYDLVIAADGLHSATRRMVFSKDDYHLRNLGCYISVFSIPNYLQLDHCETLLEAKQKLVSITSDKDSTKAFAGFMFRSSNSPNYIRDEASQKDFLRENFTNHGWESNKLLSLMNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQGTSLALVGAYILAGELKTATDHVAAFARYNELLKPYVEANQAFGVWVSESFLADEPLSAEQAEERNNIVLGIMKKATHAIELPEY	50.39	gnl|BL_ORD_ID|2785|hsp_num:0	3293		
BGC0000202.1|Azicemicin_25 # 25913 # 26737 # 1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.693	BGC0000202.1|Azicemicin_25 	25913	26737	+	Loose	400	24.6386	QnrB22	44.12	3002737	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GTGGACGTGATCTTCGGCGCGAACATCAACCCGACGCACGCCGATCCGGACGAGACGCTGCGGCTGGCCGAGCGGATCGACCGGGCGGGCCTTGACCTGGTCACCATCCAGGACCACCCGTACCGTCCGGCGTACCACGACACGTGGACTTTGCTGACATATCTCGCGGCCAGGACGCAGCACGTCTCCTACGTGCCCACCGTGGCGTGCCTGCCGTTGCGGCCGCCCGCGATGCTCGCGAAGTCCGCCGCCAGCCTGGACTCGCTGACCGGTGGGCGGCTGCGTCTCGGGCTGGGCGCGGGGGCGTTCTGGGACGACATCGTGTCGATGGGCGGCCCGCGCCGCACGCCGTCGGAGTCGGTGGACGCGTTGAGCGACGCCATCGACGTGATCCGTGCACTGTGGACCTCGCCCGACTTCGGCCCCCCGCCCGGCCCGGAACTGCAGATCTGGCTGGGTGCCAACGGGCCGAGAATGCTCGACCTGGTCGGTACCAAAGCGGACGGCTGGCAGCCGTCGCTGCTGCACATGGGGCTCGACAAGCTCCCGGCGGCGTCCGCACGGGTCGACGCCGCCGCCACGCTCGCGGGCCGTTCTCCCGACTCGATCCGCAAGGTCTACAACCTCGCCGGGACCATCGGAGCACCGTCGGCGCAACCGTTCCACGGCTCAGTGCGGCAGTGGGTGGACCAGATCGTGGACGTGGTCGGGAAATGCGGGATGAACGGGTTCGTGTTCTGGCCACAGCACGATCAGGCAAGGCAGATCGACGTGTTCGCCGCCGAGGTCGTCCCGGCCGTCCAAGCATCGATCGAGGAGGAGTGA	MDVIFGANINPTHADPDETLRLAERIDRAGLDLVTIQDHPYRPAYHDTWTLLTYLAARTQHVSYVPTVACLPLRPPAMLAKSAASLDSLTGGRLRLGLGAGAFWDDIVSMGGPRRTPSESVDALSDAIDVIRALWTSPDFGPPPGPELQIWLGANGPRMLDLVGTKADGWQPSLLHMGLDKLPAASARVDAAATLAGRSPDSIRKVYNLAGTIGAPSAQPFHGSVRQWVDQIVDVVGKCGMNGFVFWPQHDQARQIDVFAAEVVPAVQASIEEE	MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG	127.44	gnl|BL_ORD_ID|1109|hsp_num:0	1174		
BGC0000202.1|Azicemicin_26 # 26738 # 27829 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5bp;gc_cont=0.687	BGC0000202.1|Azicemicin_26 	26738	27829	+	Loose	900	54.299	iri	49.15	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCCACGCACCCAGGTCCTTGTCACCGGAGGCGGTCTGACCGGCTTGTCCACCGCGGTGTTCCTCGCCTGGCACGGCGTGCGCTGCGTTGTCGTGGAACGCGGGCCAGACCTGCCATCCCGCCCGCAGCAGCGGCCGGTGAACGCGCGGACGATGGAAGTCCTACGCCAGGTCGGCCTCGAACACATCGTGACGCGCCACAGCCAAGCGGCACACGGCATTGACGCCAGCCCATGCCCCGCAGTGACGATCATCCAGGAGTGTTTCGAGAGCTTGCTGCGTGAGCGTGCGGAGGCGCTCGGCGTCACCGTGTGCTTCGGCAGTGAACTGCGGTCCTTCAGCCAGAGCGACGAGGGCGTGACCGCGTCCGTCACCGATACCGACGGCGACTACGTGATCGACGCCGACTACCTGGTGGCCGCGGACGGCCCGCACAGCGCCACCCGTCACAGCCTCGGCCTGCTGCCCGGCGACCGGACATGCCGAGTCGGCAAGGTTTTCCTGGCTGGGAAGTCAGCGAACACGATGCCGCACGACAGCGGCGACATCTTCCTGCAGGACGCCCACAACCTGGCGTGGAAGCTCGCGGCTGTGGTCAAGGGCCTGGCCGGACCGGCGTTGCTGGACACGTACCAGACCGAACGCCACCCGGACACCGTCCCGCCCGAGGCACCGGCCGAGGCCATGACACTCGGCTTCCGGTACCAGTCGGAGGCCGTCGTGGACCCGGGCGACAACACTCCGCTGCTCCCCGGCCAACTGAACGGCCAGCCCGGCAGCCGGGCACCGCACGTCCCAGTCGCGTTCTTCGGCCGACCAGTTTCTACATTGGACCTCTACGGCCGCGACTTCGTCGTGCTGATCGGCTCCGGCGGCACCTGGCAGCACGCGGGCGAAGGCCTGCCAGTCCAGGCGTACCGCATCGGAACACACCTGCACAGCGAGGCTGATCTCGACGCGGCACACGGCATCACCGCGGCCGGAATCGTGCTCGTCCGCCCGGACGGTTTCGTCGCATGGCGCAGCCCCGGCGCGATGACAGACGCAACGGAGGCGTTGGCCAAAGCACTGCGCACCGTTCTGGCTCGCTGA	MPRTQVLVTGGGLTGLSTAVFLAWHGVRCVVVERGPDLPSRPQQRPVNARTMEVLRQVGLEHIVTRHSQAAHGIDASPCPAVTIIQECFESLLRERAEALGVTVCFGSELRSFSQSDEGVTASVTDTDGDYVIDADYLVAADGPHSATRHSLGLLPGDRTCRVGKVFLAGKSANTMPHDSGDIFLQDAHNLAWKLAAVVKGLAGPALLDTYQTERHPDTVPPEAPAEAMTLGFRYQSEAVVDPGDNTPLLPGQLNGQPGSRAPHVPVAFFGRPVSTLDLYGRDFVVLIGSGGTWQHAGEGLPVQAYRIGTHLHSEADLDAAHGITAAGIVLVRPDGFVAWRSPGAMTDATEALAKALRTVLAR	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	75.78	gnl|BL_ORD_ID|750|hsp_num:0	796		
BGC0000202.1|Azicemicin_27 # 28208 # 28306 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=6bp;gc_cont=0.626	BGC0000202.1|Azicemicin_27 	28208	28306	-	Loose	350	26.1794	APH(3')-VIIIb	47.62	3004086	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGCTTGATGTCGGGAAAACTGTCGCTGTCGCGCGCGAGAACGCGCGCGTGTTGTGGGTGACCGACGACGTGTACGTGCCCTGGAGACAGCCGGTGTGA	MLDVGKTVAVARENARVLWVTDDVYVPWRQPV	MKLPQKIRNFIGNNRLIVNKVGQSPSDVYCFERNRETFFLKVSSVQYATTTYSVAREAQMMLWLADKINVPELVFSEIDQNFEYMLSKSIDAQPISDLSLAQSELIMLYQDVLSQLRSVPVQNCPFNSDINSRLQESQYFMEIGLLNQVDDENIDIELWGEHQSYLELWTELNNHRVKENLVFTHGDITDSNIFVDQSNKIYFLDLGRAGLADEFVDIAFVERCLREDGSEESAQKFLKQLSFDDLSKRQYFLKLDELN	12.36	gnl|BL_ORD_ID|2444|hsp_num:0	2750		
BGC0000202.1|Azicemicin_28 # 28632 # 28790 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.597	BGC0000202.1|Azicemicin_28 	28632	28790	+	Loose	450	22.7126	armA	30.95	3000858	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGACCGAAACCACCGAGTACGTGTCCCGCTACGACCAACGTGTGAACCTGATCAAGGACACCCTGCGGCAACACTCGAAGCTCAACGAGAAGACCTCGCAGGACCTCGCGGAACGCATCCTCAACGCGATCGACCACATCCCCGAGACCGTCCGCTAG	MTETTEYVSRYDQRVNLIKDTLRQHSKLNEKTSQDLAERILNAIDHIPETVR	MDKNDVVKKILESKKYENLDSDIVEKVVSISEKKYKLKEVENYSKKKLHQIWGSYYSAYPNWDKLLKKYNQGQLSIEDLLKIHSSTNERVATLNDFYTYVFGNIKHVSSILDFGCGFNPLALYQWNENEKIIYHAYDIDRAEIAFLSSIIGKLKTTIKYRFLNKESDVYKGTYDVVFLLKMLPVLKQQDVNILDFLQLFHTQNFVISFPIKSLSGKEKGMEENYQLWFESFTKGWIKILDSKVIGNELVYITSGFQK	20.23	gnl|BL_ORD_ID|1320|hsp_num:0	1405		
BGC0000202.1|Azicemicin_29 # 29037 # 30098 # 1 # ID=1_29;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=11bp;gc_cont=0.677	BGC0000202.1|Azicemicin_29 	29037	30098	+	Loose	650	28.4906	vanM	39.29	3002911	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	GTGGTTTCCGCGCGTCCGATCGCTGTGGCGGCCGACACGCCGGTGATCTGCAGCGCCGGGGGCACACATCCACAGTTGCTGGCGCGGTTGCGCGACAGCGGTCTTCCGGTCGGCACGGACCTGCGCGTTTTCCGCAGCGAGGCCGATTTCGCCGACCGCGTGGCCGAAGCGATATCCGACGGGCTGCTGATGTCGATGGAGTATCCGCAGCCGATCACCCTGTGCCCGGACGAGCGCTCGCTCAAGAGCGCGCGTCTGGTCGGTCACCTGAACAACAAGGCCAGCATCACCACGTTGGTCGACCCGCGTTTCCAGGCCAACCGCAGCATCGTGACCCGAGCGAACCTCGCGGCGGCGACACCGGCCGACGAATCCTGGGTGCTGAAGGCCGCGACCAACGACGCGCACGGCGGCAGCCTCGACGTGTACCTGCACAACGCCGGAGATCACATCGAGCTGCCCGCGTTCACCGACGTGCTCGACGAGTTCGTGGTCGAGGAGTACCTGGAGATCATGACCAACTGGGGACTGCAGTTCCACGTGGGAGCGGACGCACAGGCCCGACTGCTTGCGGTGACCGAACAGCGCGTCGACGTGGTGGGGGTGTACACCGGTGGCAGGTTCGGCGCGGTCACCGATCCGCCTGCCGAACTGCTCGCGGAGTGCCTGGCGACCGCGCAGCGCGCTGCGGATCTCGGTTACCGCGGTCTGTGCAGCCTCGACTGCGCCTGGACTCGCAACGGCAGGCAGGTCCTGCTCGATCTGAACTTTCGGATCACGAGCGGCTCGATCCCGTTGCTGGCGCTCCAGTCCGTCCGGGCCGACATCCTCGACCAGCCCGCCGAGTCGGTGAAACTGACCGTCGCCGGGCCGCTGACGGACCTGCTTGACGCCGTGCACCCGGCCTTGGCCGCCGGTGGTGTGCTCATCGTGGCCGGTCACGACACTGCGCGCACGGACAATCCCGTCCGGCAGAGCACCCTGCAACTGCTGGTGTTCGGGGCCGATCCCGACGAGGTGACCGTTCGACGACAGGCGCTGGAAACAGCAACCAGCCGCTGA	MVSARPIAVAADTPVICSAGGTHPQLLARLRDSGLPVGTDLRVFRSEADFADRVAEAISDGLLMSMEYPQPITLCPDERSLKSARLVGHLNNKASITTLVDPRFQANRSIVTRANLAAATPADESWVLKAATNDAHGGSLDVYLHNAGDHIELPAFTDVLDEFVVEEYLEIMTNWGLQFHVGADAQARLLAVTEQRVDVVGVYTGGRFGAVTDPPAELLAECLATAQRAADLGYRGLCSLDCAWTRNGRQVLLDLNFRITSGSIPLLALQSVRADILDQPAESVKLTVAGPLTDLLDAVHPALAAGGVLIVAGHDTARTDNPVRQSTLQLLVFGADPDEVTVRRQALETATSR	MNRLKIAILFGGCSEEHNVSVKSAAEIANNIDIGKYEPIYIGITQSGVWKTCEKPCIDWDNEHCRSAVLSPDKKMHGLLIMQDKGYQIQRIDVVFSVLHGKSGEDGAIQGLFELSGIPYVGCDIQSSAVCMDKSLAYIIAKNAGIATPEFQVIYKDDKPAADSFTYPVFVKPARSGSSYGVNKVNSADELDSAIDLARQYDSKILIEQGVLGYEVGCAVLGNSFDLIVGEVDQIRLQHGIFRIHQEAEPEKGSENATITVPAELSAEERERIKEAAKNIYKALGCRGLSRVDMFLQDNGRIVLNEVNTMPGFTSYSRYPRMMVSAGITIPELIDHLIVLAVKE	102.92	gnl|BL_ORD_ID|1817|hsp_num:0	1924		
BGC0000202.1|Azicemicin_30 # 30100 # 30612 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.667	BGC0000202.1|Azicemicin_30 	30100	30612	-	Loose	500	24.2534	L1 beta-lactamase	44.44	3000582	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	L1 family beta-lactamase	ATGAACCCTCAATGGGAGTGGCGTGCGTCCGCGCGTTCATCTGTCAGACGCGTGTCCTTGCGGCTGACGTTGAAGCCGCCGTCGTCTCCCGCGGGGGTGGTCGACGGTGGTTGGTGGCCCCGGTCGATGGATCCCCTGGCCGAGTTCCCGGCGATGATCGCCGGTGTGACCGACCGCGTGGGTCCGGTCAACAGGGTGGCCTACAACATGGAGGCATGGGGCGAGGCGCCCCGCCGGATAGTCGTCGACGGTGAAGTGGTCCGTCTTGAAGGCGTTCGTTACCTTGATCCGCACACGGTTTTCGTGTCCGGGCACGACTGGCGGCGCAAGATCCTGTTGGTTGTCCCGCCCGATGCCAGCGAGAACACCGCGCAGGCAGCGCTGATGAGCGCCGCCAGCGAGGCTGTTCGCGATGAAGCGGAGCGAATTCTGCTCGCGGATGAGACAGGCTGCTCCGCCCCGGATGGCGCTGTTCCCGAGCCTCGCGGAAAGGCCACCGGGGCCGGAAGGTGA	MNPQWEWRASARSSVRRVSLRLTLKPPSSPAGVVDGGWWPRSMDPLAEFPAMIAGVTDRVGPVNRVAYNMEAWGEAPRRIVVDGEVVRLEGVRYLDPHTVFVSGHDWRRKILLVVPPDASENTAQAALMSAASEAVRDEAERILLADETGCSAPDGAVPEPRGKATGAGR	MRSTLLAFALSSLALAATLFTFDGAAADASLPQLQAYTVDPSWLQTMAPLQIADHTWQIGTHDLTALLVQTADGLVLIDGGMPQMASYLLTNMKARGTNTGPLRMVLLSHAHTDHAGPVAEIKRRTGAQVVVNAETAVLLARGGSDDLHFGDEITFPPVNADRIVMDREVVKLGGIAFTAHFMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDLLLTPHPGASNWNYAAGSNASEKVLSCKAYADAAEKKFDAQLAKETAGAR	57.63	gnl|BL_ORD_ID|1520|hsp_num:0	1619		
BGC0000202.1|Azicemicin_31 # 30796 # 31215 # -1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.679	BGC0000202.1|Azicemicin_31 	30796	31215	-	Loose	500	25.409	AIM-1	33.33	3000853	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	AIM beta-lactamase	ATGACCAACCAGCCGAGGTCGCTGCGGCTCGCCATCAAGGCCGATGACGCCGCGCCCAGCCGGTTCGACGGCGGATGGTGGCCTCGTTCGCCGGAGCTCGCGGTCGAACTGCCCATCCTCGTTCGCGCGCTCACCCCGCGGCTGGGCCCGGTCAGGAGAATCGGCTACAACCCGGACACCTGGGGCCTGCTGGCCAGACACATGACTGTCGACGGTCACACCACCCGGCTCGAGGGATTCACCGGCCTGGACCCCTACAGCCTCAGGATCAGCGACAGCGCAAGCAGGACGCTGTGCCTGCTGATCGTCCCGTCGGACGCCGCCGAGCACATCGGACACAGCGCGTTGACCGCCGCGTGCAAGCAGAACGGCCTGTCCCGACAGATCCTCTCCGCCTGCGGTGTGTTCAGCTACGGCTGA	MTNQPRSLRLAIKADDAAPSRFDGGWWPRSPELAVELPILVRALTPRLGPVRRIGYNPDTWGLLARHMTVDGHTTRLEGFTGLDPYSLRISDSASRTLCLLIVPSDAAEHIGHSALTAACKQNGLSRQILSACGVFSYG	MKRRFTLLGSVVALALSSTALASDAPASRGCADDAGWNDPAMPLKVYGNTWYVGTCGISALLVTSDAGHILVDAATPQAGPQILANIRALGFRPEDVRAIVFSHEHFDHAGSLAELQKATGAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVAPVANIVTLADDGVVSVGPLALTAVASPGHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVFRYSDDAAHPGYLAAFRNTLARVAALDCDILVTPHPSASGLWNRIGPRAAAPLMDTTACRRYAQGARQRLEKRLAEEAATSPSSGARP	45.87	gnl|BL_ORD_ID|665|hsp_num:0	707		
BGC0000202.1|Azicemicin_32 # 31607 # 31912 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.719	BGC0000202.1|Azicemicin_32 	31607	31912	+	Loose	1500	22.3274	rphB	28.81	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGAAGCCCGTGGGCGCGGCAAACGGCCCCTTCGACGGTGGTGAGCGGCCGCGGTCGAACGAGCCGGTGGCCGTGGTGATCGGAGCAGACTCGCGGCGGGTCCGCCTGCTGGTGGTGCCACCGGCCACACCCGGCAGGACGGCTCGTGCCGTGCGGTCCGCCGCGGATGCGGCCGCCCGTGTAGCCGACATCCTCGGCGGCAGCAGCGCTTCGAGCACCCCGGACACCAAGGACAAGCAAGCCACCCATCCCGCGCCAGCGGTCCCGCAACAGGGACGGCGCCAGCCAGGAGACCAGTCAATATGA	MKPVGAANGPFDGGERPRSNEPVAVVIGADSRRVRLLVVPPATPGRTARAVRSAADAAARVADILGGSSASSTPDTKDKQATHPAPAVPQQGRRQPGDQSI	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	11.43	gnl|BL_ORD_ID|2298|hsp_num:0	2528		
BGC0000202.1|Azicemicin_33 # 31909 # 32955 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=10bp;gc_cont=0.642	BGC0000202.1|Azicemicin_33 	31909	32955	+	Loose	900	25.0238	emrB	29.79	3000074	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCACAGTGGACACGTCACTTTCGGACGTCGCTGATCCGCAGCGAGGCAGCGACTTCGCCCGACTAGCCAAGGAAATCAAGAAGGCCGGTTTGTTGGACCGGCGACACGGGTACTACTTCACACGGATGGCGGTCAACGTCCTGCTGCTCGCGGCAGGCTGCGTGGCCTTCGCCATGATGGGTGACTCGTGGTGGCAGCTGTTGATCGCGACCTTCCTCGCGATGGTGTTCACCCAGTTCGCCTTCATCGGACACGACGCCGGGCACAAGCAGATCTTCCGCAGCAGCCGACGCAACAACTTCGTCGGCTACCTGCACGGCGGGGTCACCGGGATCAGCTACCAGTGGTGGGTCGCCAAACACAACCTGCACCACGCCAACCCCAACCACGAGGACCAGGATCCCGACATCGACCTCCCCGCACTGGCCTTCAGCCGTGCCCAGTCGGGCACCAAACAAGGCATCTACCGGTGGATCACGAAGTACCAGGCCTTCCTTTTCTTCCCCCTGCTGCTGCTGGAGGCGGGCATGCTGCGGATCGCCAGCATCCAGGCGGTCGTGCGCCGCGAGGTCAACCGGCCGGTGCTGGAAGCCGCCCTGTTGACCATCCCCCTCGCCGGGTACCTGACAGCGCTGTTCCTCGTGCTGTCGCCAGGGCAGGCGATCCTGTTCATCGTCATCCACCAGGGCCTGATGGGCGTCTACCTCGGCTGCTCGTTCGCACCCAACCACAAGGGCATGCCCATCCTGACCAAGGAGCAGGAGCTGGACCACCTGCGCAAACAAGTGCTGACCTCGCGCAACATCTCGGGCGGCCGCTGGGTGGACGGGTTGCTCGGTGGCTTGAACTACCAGATCGAGCACCACCTGTTCCCGCACATGCCCCGGCCCAACCTGCGCCGCGCACAGCCCATCGTCGAGGGCTTCTGCGGACGGCACGGCATCCCCTACAGCAAAGCCACACTGCTCAACTCGTACGCACAAGTGCTGCGCCACCTGCACGATGCCGGTTCGCCGCTGCGCAACCGGACGGCATCCTCATAG	MTTVDTSLSDVADPQRGSDFARLAKEIKKAGLLDRRHGYYFTRMAVNVLLLAAGCVAFAMMGDSWWQLLIATFLAMVFTQFAFIGHDAGHKQIFRSSRRNNFVGYLHGGVTGISYQWWVAKHNLHHANPNHEDQDPDIDLPALAFSRAQSGTKQGIYRWITKYQAFLFFPLLLLEAGMLRIASIQAVVRREVNRPVLEAALLTIPLAGYLTALFLVLSPGQAILFIVIHQGLMGVYLGCSFAPNHKGMPILTKEQELDHLRKQVLTSRNISGGRWVDGLLGGLNYQIEHHLFPHMPRPNLRRAQPIVEGFCGRHGIPYSKATLLNSYAQVLRHLHDAGSPLRNRTASS	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH	67.97	gnl|BL_ORD_ID|1745|hsp_num:0	1847		
BGC0000202.1|Azicemicin_34 # 32978 # 33838 # -1 # ID=1_34;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.689	BGC0000202.1|Azicemicin_34 	32978	33838	-	Loose	275	25.409	AAC(6')-Ir	40.48	3002561	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGTTCCTCGCAGTCACGTTCACCGGCGTGTCCGCCGTCGGGATCTGGTGGGCACTGACCGGCGACATCACCGATGAGGCGGACCAGCTGCGCTACGGCGGGCTGGCCATGTTCACCCCGACCTTGGGCATGCTCGCCGCAGCCGCGGCGAGCGGGACTCTGCGGCGACCGAAGGAGCTCCTCGCCAGCACCGGCATGCTCGTGTCCGGCAGGTGGTCCACGATCCTGCGGTACTGCGCGATCGGTGTGCTGCTGCCGCTTGTCATCCTTGCCGCCACACTCGGCATCAGCGTGCTGCTCGGTGAATACCACCTGCGCCAGCCGCTCCCGTGGGGCGAGTTGACCATGACCGTCGCCATGTCGGTGCTGACGTTCGTCCCGGCGCTGGTACTCGTCCTCGGTGAGGAACTCGGCTGGGGTTATCTGCTGCCCCGGTTACTGCCACTCGGGCTCTGGCCCGGACTGCTGCTGGCGGGCCTGCTCTGGGGGCTGTTCCACGCGCCCCTGACCCTGCAGGGGTACGGCTACCCGGACCAGAACGGACTCGTGGCGACGCTGATGTTCACCGTCGCCCACGTGTTGCTGGGCACCCTCATGGGCTGGATCAGGCTGGCGTCGGGCAGCGTGTGGCCGGCCGTCGCGCTGCACGGCGCGTCCAACATGCTCGCCAACCCCATTCCGGCGGTGATCGGGCAGACGGCCGATCCGGCGCGACTGGGCCAGTACGCCGCCGTGCCGACCGCGTGGCCCAGTTGGTTCGTGCTGGCGGCTCTGATCGGCATCCTCGCCTGCCGTGGCCATTATCGTCGGCCCTTCGACCACATACGGCATGGCGCAGACCAGCCTCAGCGCTTCGAGTAG	MFLAVTFTGVSAVGIWWALTGDITDEADQLRYGGLAMFTPTLGMLAAAAASGTLRRPKELLASTGMLVSGRWSTILRYCAIGVLLPLVILAATLGISVLLGEYHLRQPLPWGELTMTVAMSVLTFVPALVLVLGEELGWGYLLPRLLPLGLWPGLLLAGLLWGLFHAPLTLQGYGYPDQNGLVATLMFTVAHVLLGTLMGWIRLASGSVWPAVALHGASNMLANPIPAVIGQTADPARLGQYAAVPTAWPSWFVLAALIGILACRGHYRRPFDHIRHGADQPQRFE	MKIMPVSEPFLADWLQLRILLWPDHEDAHLLEMRQLLEQPHTLQLLSYNDQQQAVAMLEASIRYEYVNGQQSSPVAFLEGIYVLPEYRRLGVASTLVQQVEHWAKQFACTEFASDAALDNTISHAMHRALGFQETECVVYFKKNIS	195.89	gnl|BL_ORD_ID|1721|hsp_num:0	1821		
BGC0000202.1|Azicemicin_35 # 33972 # 34616 # -1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0000202.1|Azicemicin_35 	33972	34616	-	Loose	390	73.9442	evgA	26.84	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATCCGGGTGCTGGTTGCCGACGACCAGGCGATGGTGCGCGCCAACTTGTGCGTCATCCTGGACGCCCAACCGGATATCGAGGTGATCGGTTCGGCCGCTGATGGGCAGGCGGCCGTCGACCTGGCCCGACGGTTGCGGCCCGATGTCGTTCTCACCGACATCCGGATGCCGCGCCGCGACGGCATCGCGGTCACCCGTGCGCTGGCAGGCGTCGGCATCACCGATCCGATCCGGGTGGTGGTGCTCACCACGTTCGACCTCGACGAGTACGTGTACGACGCCCTGCACGCGGGGGCGTGCGGGTTCGTCCTGAAGCGTTCCGGCCCGGTTCTGCTCGTCGAGGCCGTGCGGGCGGCTTTCCACGGCGACACGCTGATCAGCCCGTCGGTGACCACCCGCCTGCTTCGGCACCTCACCGGGCGGGACGACGAGCCCGATGCGCTCGCGGAGCCACTCACCGCCCGCGAACGGGAGGTCGCCGGGCTGGTGGCCGACGGTCTGACCAACGCCGAGATCGGCACCAGGCTGTTCATCTCCGCCGGTACCGCGAAGACGCACGTGGCCAACGTCCAGCGCAAGCTCGGCGTCCGCAACCGGGTCGGGATAGCCATCTGGGCACAGGCCAGAGGACTCGCCACCTGA	MIRVLVADDQAMVRANLCVILDAQPDIEVIGSAADGQAAVDLARRLRPDVVLTDIRMPRRDGIAVTRALAGVGITDPIRVVVLTTFDLDEYVYDALHAGACGFVLKRSGPVLLVEAVRAAFHGDTLISPSVTTRLLRHLTGRDDEPDALAEPLTAREREVAGLVADGLTNAEIGTRLFISAGTAKTHVANVQRKLGVRNRVGIAIWAQARGLAT	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	104.90	gnl|BL_ORD_ID|958|hsp_num:0	1015		
BGC0000202.1|Azicemicin_37 # 35916 # 36884 # -1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000202.1|Azicemicin_37 	35916	36884	-	Loose	600	29.261	IMI-8	51.72	3003142	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IMI beta-lactamase	ATGACCAGCCCGATCGCCCTGCTGCTGCCAGGGCAGGGCGCGCAGTACCCCGGCATGGCCCTGGAGCTCTACGGTGTGGAGGAGGTCTTCACCGCGGCCATGGACGAGTTCTTCGAACTCATGGGCGCGGTGGGGACCGAGCTGCGGGCCGACTGGCTCAGTGACCAGCCGGTCGTCCCACTCGACGACGCGTCGCGCGCGCAGCCGTTGCTCTTCGCCATCGGCCACGCACTCGGCAGGACGCTGATGGCGAACGGGTCCACTCCGTCCGTCCTGATCGGACACAGCGTCGGCGAGCTGGCCGCGGCCGCACTGGCGGGGGTCTTCGACCCGCCAGGCGCGGCCCAGGTCATCCTGGCCCGCTACGAGGCGATGGCCACCGCCCCACGCGGTGGCCTGCTCGCCGCATCGGCGGCGGCGAGTGAGGTCGAACGCCACCTGGATGCCCGAGGCCACGACGAGGGCGTGGGCATCGCGGCGGTCAACGCCCCGAACCTGACCGTGGTCTCCGGAACCGAAGCCGGGCTGGCCCGGGTGCGGGAGACGTTGTCGGCCAACGGTATCGGCTCGATGCGAGTGGGCTCCCGCCAACCGTTCCACTGCCCGGCGGTCGCGGCGGCAGCGGAGAAGTTCGAGGCAGGATTCGCCGGGGTGACGTTGCGCCCGCCCCGGATTCCGATCATCTCCACCAGAACGGCCAGCCCGGTAACACCCGAGCAGGCCATGACACCGGAGTTCTGGGCACGGCAACTCGACGCGCCCGTGTTGTTCTGGCCCGCCGTGGACAGCCTGCTCACGTCGGGCAGCTACACGGTGGTCGAGGCAGGGCCGGGAAAGGGACTGTCCATGTTGGCCAAGAAACACCCCGCTGTGCGGGCCAGGCGAAGCAGCGTCTATTCGTTGTCGCCGTCACGGGCCAGTGGCACGTTGACAGCATGGCGGGCTGGGCTCGACCAGCTGAACTCCTGA	MTSPIALLLPGQGAQYPGMALELYGVEEVFTAAMDEFFELMGAVGTELRADWLSDQPVVPLDDASRAQPLLFAIGHALGRTLMANGSTPSVLIGHSVGELAAAALAGVFDPPGAAQVILARYEAMATAPRGGLLAASAAASEVERHLDARGHDEGVGIAAVNAPNLTVVSGTEAGLARVRETLSANGIGSMRVGSRQPFHCPAVAAAAEKFEAGFAGVTLRPPRIPIISTRTASPVTPEQAMTPEFWARQLDAPVLFWPAVDSLLTSGSYTVVEAGPGKGLSMLAKKHPAVRARRSSVYSLSPSRASGTLTAWRAGLDQLNS	MSINAKKSKAAVFLSYFLIPISFYSQADTNAMDEIKKLETGFGGRVGVYALDTGSGKSFSYRANERFPLCSSFKGFLAAAVLKGSQDNQLNINEIVNYNKRSLEPHSPITQKYKENGMSLGDMAAAALQYSDNGAANIILERYIGGPEGMTNFMRSIGDEDFRLDRWELDLNTAIPGDERDTSTPAAVGKSLKNLALGNILNDHEKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGTCGAYGTANDYAVVWPKNRAPLIISVYTTKSEKEAKHDEKVIEEASRIAITHLK	110.27	gnl|BL_ORD_ID|2643|hsp_num:0	3617		
BGC0000202.1|Azicemicin_38 # 36887 # 37213 # -1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.621	BGC0000202.1|Azicemicin_38 	36887	37213	-	Loose	275	26.9498	AAC(6')-Iih	29.63	3002590	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGTACACCACGTTGATCGTCGGGCGGATGAACCCGGCCGAGAAGGAACTGGTCGCCGGTCACTTCGCGAACTTCGACGCCTCCGAGATGCCGCATCTGATGGGCACGCGGCGGCGTGAGCTGTTCAACTACAACGACCTGTACTTCCACCTGCAGCAGTTCGACGACGACCACGACTCGGGCGAGGCGATCCGCAACGCGATGGACCACCCGCTGTTCGTCGACATCAGCCAGAAGCTGATCGCCATGATCGACCCCTACGACCCGAAGACGTGGAAGCAGCCGACCGACGCGATCGCCAAGTCGTTCTACCGCTGGCAGCCCTGA	MYTTLIVGRMNPAEKELVAGHFANFDASEMPHLMGTRRRELFNYNDLYFHLQQFDDDHDSGEAIRNAMDHPLFVDISQKLIAMIDPYDPKTWKQPTDAIAKSFYRWQP	MIISEFDRDNLVLRDQLADLLRLTWPDEYGEQPMKEVERLLEDERIAVSAIEGDELIGFVGAIPQYGQTGWELHPLVVESMYRKQQVGTRLVSYLEKEIASQGGIVVYLGTDDVEGQTSLAIEEDLFEDTFDKLETIQNRKDHPYEFYEKLGYQIVGVIPDANGWNKPDIWMAKRIARKHGSE	59.02	gnl|BL_ORD_ID|1787|hsp_num:0	1891		
BGC0000202.1|Azicemicin_39 # 37231 # 37962 # -1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=AGGG;rbs_spacer=11bp;gc_cont=0.695	BGC0000202.1|Azicemicin_39 	37231	37962	-	Loose	500	26.5646	ErmF	29.27	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCTCGGCGGGACGGACAACTTCGAGGCCGACCGCAGGGTCGGCGACGACCTGATCGCCGCCATGCCGTGGATTCGCGGTGTGGTCAGGGCGAACCGGGCGTTCCTCGGCCGGGCCGTGCGGTTCGCCGCCGAGTCGGGAGTCGGGCAGTTCCTCGACCTCGGCGCGGGCTTGCCGACCTCGCCGAGCACGCACGAGGTGGCGCGGCAGGTGATCCCGGACGCCACAGTGGCCTATGTGGATACTGATCCGATCCTGCTCGACCACGCACGCAAGCTGCTAACCGGCGGCCTCGACTCGACGGCGGTCGTCCAGGCGGACGTGCGGGACGCGGCGGCGACGCTGAACCAGCCGGAACTGCGGCGGGTGATCGACCTGGACAAGCCGGTCGCGGTGATGCTGATCGGCCTGATGCACCTGTTCCACGACGCCGACGACCCGTACGACATGGTCGCGAAGTACCTCGCGGCGGTGCCCTCCGGCAGCATGCTGCTGTTCTCCCAGTTCACCGCGGACTTCACCCCGGAGACCGCGGGGGAGTTGCAGCGGATCTCCAGCGAGGCCGGTGAGCCCGTCGCGATGCGGTCGCGTGCGGAGATCGCCCGGTTCTTCGACGGACTGGACATCGTGGAGCCCGGTCTCGTGCAGATGCCGAAGTGGCGCCCCGACGGTGAACCGTCGGACGGTTCCGAGCACGTCTTCCTGTACGCGGGCGTCGCCCGCAAGCCGTGA	MLGGTDNFEADRRVGDDLIAAMPWIRGVVRANRAFLGRAVRFAAESGVGQFLDLGAGLPTSPSTHEVARQVIPDATVAYVDTDPILLDHARKLLTGGLDSTAVVQADVRDAAATLNQPELRRVIDLDKPVAVMLIGLMHLFHDADDPYDMVAKYLAAVPSGSMLLFSQFTADFTPETAGELQRISSEAGEPVAMRSRAEIARFFDGLDIVEPGLVQMPKWRPDGEPSDGSEHVFLYAGVARKP	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	91.35	gnl|BL_ORD_ID|582|hsp_num:0	621		
BGC0000202.1|Azicemicin_40 # 38226 # 39245 # 1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=AGGGAG;rbs_spacer=7bp;gc_cont=0.689	BGC0000202.1|Azicemicin_40 	38226	39245	+	Loose	500	32.7278	chrB	42.5	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGCGGCAGGATGCGGGTCAGGCGCTGATGCGGCTGGTGTGGGGCTACACGAGCACCGGGCTGGTCGTCGCCGCGATGCGGCTCGAACTCCCCGACCGGCTCGCGAGCGCGACGCGGTCCACGGTGGACCTCGCGGACGAGATGGGCGTGCACGAACCGTCGCTGCGCCGCCTGTTGCGGGCGTTGACGGCGATCGGTCTCACCAGTGAGACCAGTGCAGGACACTACGCGTTGACACCGGTGGGCGCGTTGCTCCGCAAGGACGTCCCCGATTCCCTGCACGCCGTCGTCCGGGTCAGCACCGACGAGACGATCCTGCGCGGCTGGCGTGATCTCGACTGGAGCGTCCGCACCGGGCAGACGGCGTTCGACCGGATCCACGGAACGGACTTCTTCGCCCATATCGCCGAGAACGCGGAATTGTCGGCATTGTTCAACGCGTCGATGGGTGCGGGCACGACCGAGGTCGCCGAGGCGGTCACGAAACACTACGACTTCTCCCGGTTCGGCACGGTGGTGGACGTCGGCGGCGGGAACGGCACCCTGCTCGCCCCGATCCTCGCCGCCGAACCGGAACTGCGGGGAATCGTGTTCGACAGCGAGGAGGGCGTCGAACAGGCGGCCGGGGTGCTGGCGGACGCGGGCGTCGCGGACCGCTGCGAGATCGTCGCCGGGGACTTCTTCCGCGCGGTGCCCCGCGCGGATCTCTACCTGCTCAAGAACATCCTGCACGACTGGGACGACACCCGGTCGGCGGCGATCCTCGCCAACTGCCGTGCCGCGATCCCGGAGCACGGCAGGCTCCTGCTGGTCGAGTCGGTGCTGCCGGCCACCCCCGAGCCGGGCGGGCCACCGGACGACTACCTGATGGACATCAACATGCTGGTCAACTTCGGCGGCCGGGAACGCACCGAAGGCGAGTTCCACGCCTTGCTCACTGCGGCTGGGTTCCAGCCACGGCACGCGGTGCGGGTGGGCGAATTAGACGACCACCTCATCGAAGCCGTTCCAGTCACCTGA	MRQDAGQALMRLVWGYTSTGLVVAAMRLELPDRLASATRSTVDLADEMGVHEPSLRRLLRALTAIGLTSETSAGHYALTPVGALLRKDVPDSLHAVVRVSTDETILRGWRDLDWSVRTGQTAFDRIHGTDFFAHIAENAELSALFNASMGAGTTEVAEAVTKHYDFSRFGTVVDVGGGNGTLLAPILAAEPELRGIVFDSEEGVEQAAGVLADAGVADRCEIVAGDFFRAVPRADLYLLKNILHDWDDTRSAAILANCRAAIPEHGRLLLVESVLPATPEPGGPPDDYLMDINMLVNFGGRERTEGEFHALLTAAGFQPRHAVRVGELDDHLIEAVPVT	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	121.07	gnl|BL_ORD_ID|284|hsp_num:0	305		
BGC0000202.1|Azicemicin_42 # 40376 # 41860 # 1 # ID=1_42;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.709	BGC0000202.1|Azicemicin_42 	40376	41860	+	Loose	550	26.1794	ARL-1	43.48	3004734	protein homolog model	n/a	n/a	penam	antibiotic inactivation	ARL Beta-lactamase	ATGACCCTGTTACACCACATCGTCGACGAGGCCGCCGCGCGATGGCCGGACCGCCCGGCCATCACCGGTGGCGACATCACTCTCACCCATCAGGAGCTCGCGGCGGCGAGCCGCCGGACCGCGCACTGGTTGTTGGACACGGGTGTGCGGCGGGGCGACCGCGTCGTGTTCGTGAGCCCGTCGTCCGTGCTGCACCCGGTGCTGATCTACGCGGCGTCCCGGATCGGCGCAGTCGTCTCGATCCTGCACGAGCAGACCACCGAGCGGTCGCTGGCGCACGTGCTGGACGACTGCGAGCCGGTGCTGCTCATCTCGGACGACTTCACCGAGTTGGCCCGCAGCAGGGGCATCCGGGCAGCGGGCACGGACGATCTCGCCGGGCCCGCGCTGCGGGAAGGCGGGGACGCGGACACCGCGCCGGAGCCGTTGGCGGTGGATCCGCTGTTCCTGCTCTACACCTCGGGGACCACCTCGGCGCCGAAAGCCGTGGTGAGCACACACCAGTCGGTCGTGTTCGCGGTCAACGCCATCCAGTCCGTGCTGCGCTACGCCGAATCGGACGTCGTCTACTGCCCGTTGCCGCTGTCCTTCGACTACGGCATGTACCAGCTGTTCCTCGGTGCCGCGTCCGGCGCCGGGATCTGGCTGGGGCGCCCGGCCGAGGTCGGCCCTTCGCTGGTACGCAAGCTGGTCGCGGCGAAGGCGACGGTCCTGCCCGCGGTTCCCGCCGTGGCGGAGGCGCTCGCCCGCCTCCTGCCCCGCCACCAAGGCCCGAAACCAGCGCTGCGGCTGCTGACCAACACGGGAGCGGCGATGCCCGCGGCCGTGCTGTCGTCGCTGCGGTCGGCTGTCGCGGGACTGTCGGTCCAGTTGATGTTCGGGCTGACCGAGTGCAAACGCGCCACGATCGCGCCGCCGGACGCCGACCTGGACAACCCCGGCACCTGCGGCGTGCCACTGCCGGGCACCGAGGTGTTCACAGTGGACGAGTCGGGCAACCGGCTTGGCGCGGGCGAGATCGGCGAGATCACGGTTCGCGGGCCGAACGTGATGTCCGGGTACTGGCGGCAGCCCGAGATGACCGCGAAGCGGTTCGTCCGCCGCGAGGGGCTCCTGCCCGAGCTGCGCACCGGCGACCACGGCTGGCTGGACGAGGCCGGTCACCTGCATTTCGTCGGCAGGCTCGACGACATCTACAAGGAGCGTGGGCTGCGTGTCAGCGCCACCGAGGTGGAGACGGCCGCGCGGCGGGTCGCCGGGGTGGAGTCCGCTGTCGTGCTGCCGCCGGGAGATGGCCGCCCTGCCGTGCTCGTGGTGGTGACCGACCACGCCCCGCAGCACGTCCTAGCCGGGATGCGGCAGGAGATCGAGGAGTTCAAGATCCCTGGCCGCTGTCTCGTGGCCGACCGGCTTCCGTTGAACGGCAACGGGAAGGTCGACCGCAAAGCAGTGGCCGCACTACTCGTGGAGGCCGACGGTGGATGA	MTLLHHIVDEAAARWPDRPAITGGDITLTHQELAAASRRTAHWLLDTGVRRGDRVVFVSPSSVLHPVLIYAASRIGAVVSILHEQTTERSLAHVLDDCEPVLLISDDFTELARSRGIRAAGTDDLAGPALREGGDADTAPEPLAVDPLFLLYTSGTTSAPKAVVSTHQSVVFAVNAIQSVLRYAESDVVYCPLPLSFDYGMYQLFLGAASGAGIWLGRPAEVGPSLVRKLVAAKATVLPAVPAVAEALARLLPRHQGPKPALRLLTNTGAAMPAAVLSSLRSAVAGLSVQLMFGLTECKRATIAPPDADLDNPGTCGVPLPGTEVFTVDESGNRLGAGEIGEITVRGPNVMSGYWRQPEMTAKRFVRREGLLPELRTGDHGWLDEAGHLHFVGRLDDIYKERGLRVSATEVETAARRVAGVESAVVLPPGDGRPAVLVVVTDHAPQHVLAGMRQEIEEFKIPGRCLVADRLPLNGNGKVDRKAVAALLVEADGG	MKKFFTIFVLLCVCFAYTTATASAQGLTKLEHKNDATVGVYGINTATGQTYSHNADTRFAYASTFKAITSGLLLQQNSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQSDNTASNIIMEQLGGLDQLSSRLQALGDTTTNPQRYEPELNNYDPQSTADTSTPRATAHNLQKLLTTDAVAPQQRKFLQNLMFNNKTGESLIKKGVPNSYKVGDKSGQGTTYGTRNDVAVIYPKHQTKPIILVVFTKHQQQDAQPQDELVAQAARHAIHQLD	175.18	gnl|BL_ORD_ID|2437|hsp_num:0	3549		
BGC0000202.1|Azicemicin_43 # 41853 # 43043 # 1 # ID=1_43;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.699	BGC0000202.1|Azicemicin_43 	41853	43043	+	Loose	600	26.5646	vanHO	42.31	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GTGGATGACAAGCTGCCGGAGACCCCGGCCTACGTCTACGACCTGGCCGAGGTCAGGGCCAACCAGACCGCCCTGGTCCGCGCCCTGCCGGAGAAGTCCGTCCTGTACTACTCGCTGAAGGCGAATCCGCACCCGGACCTGCTCGCCGAGATCCGGAAAGGCGGTGCCCGCGCGGAGGTGTGTTCGCGGGGCGAGCTCGACGCGGCGCTCGCGGCGGGCTGGCCTGTCGACGACGTGCTGTACACGGGCCCCGGCAAGCGCGACCAGGATCTCGCGTACGCCATCGAACTGGGCGTCCGGAAGTTCTCCGTGGACTCGGTGACCGGCCTCGACCAGCTCGACCGCGTCGCCGCCGTGCAAGCGACCGAGGTCCGGTGCCTGTTGCGGATCAACGACGACCAGCCGGTGCCGGGCCAGGGCCTGGTGATGACCGGTGTGGCGTCCCAGTTCGGCGCCGACACGTCGTGGGTGCTCGCCGAGCCGGAGCGGTTCGCGGGCAGGCCGCACGTGATCGTGTCGGGGCTGCACCTGTACATGGGCACCAATCTGGCCACTGTGGACGATCTGGTCGCGCAGTTCCGGCGGTCACTGGACACCGGGATCCGGCTGACCGAGGTGTTGCGGCAGCACGGCGCCGACATGCACATGCTCGACCTCGGCGGCGGATTCGGTGCCCCGTTCGCCCGCGGCGGCGCGGCGGTGGACCTCGCCGGGCTGAAGGACGAACTCGACCGGATGCTCGACGGGCACGACCTGTTCATCGCGTTCGAGTCCGGCCGCTACCTGGTCGGCACCGCGGGCACGCTGTACACGACGGTGCTGGACGTCAAGCAGTCACACGGCAAACGAGTTCTGGTGCTGGACTCCGGGATCAACCACCTCGGCGGCATGTCCGGACTGCGCCGCCTGCCGCCGCTGGTGCCGGACGTACTCGCGGACCACGGCGAACTCGCCGACGCGATGCTGGCCGGTCCACTGTGTACACCGTTGGACCTGTGGGCGCGTTCGGCCCCGGTCGGCGAGGTCAAGCCGGGTGACGTGCTCGCGATCCCGAACGTCGGCGCGTACGGCCTGTACGCCAGCCTCGTCGCGTTCCTCGGCCACCCGCTGCCCGTCGAGGTCGTCGTCGACGGCGACGCACCACCCAGGATCTCCCGGCTCATTCTCACCCGGAACCCAACGGAGACATGA	MDDKLPETPAYVYDLAEVRANQTALVRALPEKSVLYYSLKANPHPDLLAEIRKGGARAEVCSRGELDAALAAGWPVDDVLYTGPGKRDQDLAYAIELGVRKFSVDSVTGLDQLDRVAAVQATEVRCLLRINDDQPVPGQGLVMTGVASQFGADTSWVLAEPERFAGRPHVIVSGLHLYMGTNLATVDDLVAQFRRSLDTGIRLTEVLRQHGADMHMLDLGGGFGAPFARGGAAVDLAGLKDELDRMLDGHDLFIAFESGRYLVGTAGTLYTTVLDVKQSHGKRVLVLDSGINHLGGMSGLRRLPPLVPDVLADHGELADAMLAGPLCTPLDLWARSAPVGEVKPGDVLAIPNVGAYGLYASLVAFLGHPLPVEVVVDGDAPPRISRLILTRNPTET	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	113.14	gnl|BL_ORD_ID|741|hsp_num:0	786		
BGC0000202.1|Azicemicin_44 # 43045 # 43299 # 1 # ID=1_44;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.671	BGC0000202.1|Azicemicin_44 	43045	43299	+	Loose	300	27.335	dfrE	39.39	3002875	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGGACGCGCGTTTCACCGAGTTGCTCGGCAAGTTCCTGAAGTTCGCCGACGGCAAACCGATCACCGCGGACTCGGACCTGCGGGCGCTCGGACTGGACTCGATGCAGTCCATCGAGTTGCTGTTCGCCATCGAGGACACCTACGGCATCACGCTGCCCGACGACGAGATGGGCGACGCGACCTTCGCCACCGCGGGCAGCCTGTGGCAGGCGATCGCCGCGGAACTGCCCGACGGGACGGGGGCGGTGGCATGA	MDARFTELLGKFLKFADGKPITADSDLRALGLDSMQSIELLFAIEDTYGITLPDDEMGDATFATAGSLWQAIAAELPDGTGAVA	MLAAIWAQDEQGVIGKEGKLPWHLPNDLKFFKEKTIHNTLVLGRATFEGMGCRPLPNRTTIVLTSNPDYRAEGVLVMHSVEEILAYADNYEGVTVIGGGSVVFKELIPACDVLYRTMIHETFEGDTFFPEIDWFVWEKVATVPGVVDEKNLYAHDYETYHRNDK	51.22	gnl|BL_ORD_ID|1453|hsp_num:0	1544		
BGC0000202.1|Azicemicin_45 # 43296 # 44444 # 1 # ID=1_45;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=7bp;gc_cont=0.705	BGC0000202.1|Azicemicin_45 	43296	44444	+	Loose	750	26.9498	patB	36.96	3000025	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAGCGAGCTGACCGCACTGGTCGACCAGGTCGTCCAGACGGCCGAGCGGCACGTCGCCACCGCCGACCGGGACGCGGCCTTCCCGGTCGAGGCGCTGGCGCAGTTGCGCCGGACCAAGCTGCTCGGCCTGCTCGTTCCCGCCGAACACGGCGGTCTCGGCGGCACGCTGAGCGATGTCGTCGACGTGGGCATCAGGCTCGGCCGGACCGACATGTCACTGGCGATGATCTTCGTGATGCACTGCCAGCAGGTGGCGGCGGTGGTCCGGCACGCACACGAGCCGTTCCGCGCGGATCTGCTGAAACGCGTCGGGCAGGGCCAGGTGTACCTGGCGTCGGTGACCACCGAGGCGGGCAAGGGCGGCCACCTGCGCAGCGCGGAGTCGGCGCTGAGCGGGGACACGACACTGGCCATCGACCGGTTCGCGCCGATCGTGACCGGGGGCGTGTACGCGGACGGCTTCCTGATCACCATGCGCAGCCCGAACGCCGACTCCCCCAACCAGGTCTCGCTGGTCTACGCCGACCGCGACCAGGTGGAGGTGACCGCGTCCGGCGACTGGCAGCCGATGGGGATGCGAGCCAGCCACAGCGTGCCGATGAAGCTGGTCGGCAGTGTGCCCGCGGAGCAGGTGATCGGCGAGCACGGGGCGTTCCCGGACATCGCCACCACGATCTTCGCGCCGCTGGCCCATCTGGGCTGGTCCGCGGCCTGGCTCGGGACCGCGGCAGGTGCGTTGTCCCGTGTGCTGCGGATGATCCGCGGCAAGGACGGGCGTGACCGGTTCGACGTTCGCTCGGAGCTGTTGCTGACCAGGCTGTCCACCGCGCGGCAACGGCTCGACGGCGTGCACGCCCTGCTGCGGCGGGCGGAGCAGACCGTGCGCACGTCGCCGGACCTGTCCGTGCCGACCAACCAGTTGCTGCTCAACGCGCTGAAGATCACCGCGGCCGAGCAGTGCCACGCGGCGGTGAACGACCTGGTGGACGCGGTCGGGCTGCGACACGGCTATCTCAAGGACTCGCCGACCCGGTTGGAACTGGCACTGCGTGACCTGCGGTCAGCGGCGCTGAACTACAGCAACGACCGGCTGCACCTGGCCGACGGCAGGCTGGCACTGCTCGACCCGGAGGTCCGCTTTGTCTGA	MSELTALVDQVVQTAERHVATADRDAAFPVEALAQLRRTKLLGLLVPAEHGGLGGTLSDVVDVGIRLGRTDMSLAMIFVMHCQQVAAVVRHAHEPFRADLLKRVGQGQVYLASVTTEAGKGGHLRSAESALSGDTTLAIDRFAPIVTGGVYADGFLITMRSPNADSPNQVSLVYADRDQVEVTASGDWQPMGMRASHSVPMKLVGSVPAEQVIGEHGAFPDIATTIFAPLAHLGWSAAWLGTAAGALSRVLRMIRGKDGRDRFDVRSELLLTRLSTARQRLDGVHALLRRAEQTVRTSPDLSVPTNQLLLNALKITAAEQCHAAVNDLVDAVGLRHGYLKDSPTRLELALRDLRSAALNYSNDRLHLADGRLALLDPEVRFV	MKTVQFFWHYFKVYKFSFVVVILMIVLATFAQALFPVFSGQAVTQLANLVQAYQNGNPELVWQSLSGIMVNLGLLVLVLFISSVIYMCLMTRVIAESTNEMRKGLFGKLAQLTVSFFDRRQDGDILSHFTSDLDNILQAFNESLIQVMSNIVLYIGLILVMFSRNVTLALITIASTPLAFLMLIFIVKMARKYTNLQQKEVGKLNAYMDESISGQKAVIVQGIQEDMMAGFLEQNERVRKATFKGRMFSGILFPVMNGMSLINTAIVIFAGSAVLLNDKSIETSTALGLIVMFAQFSQQYYQPIIQVAASWGSLQLAFTGAERIQEMFDAEEEIRPEKAPTFTKLQESVEISHIVFSYLPDKPILKDVSISAPKGQMTAVVGPTGSGKTTIMNLINRFYDVDAGGIYFDGKDIRGYDLDSLRSKVGIVLQDSVLFSGTIRDNIRFGVPDASQEMVEVAAKATHIHDYIESLPDKYDTLIDDDQSIFSTGQKQLISIARTLMTDPEVLILDEATSNVDTVTESKIQHAMEVVVAGRTSFVIAHRLKTILNADQIIVLKDGEVIERGNHHELLKLGGFYSELYHNQFVFE	64.97	gnl|BL_ORD_ID|1957|hsp_num:0	2112		
BGC0000202.1|Azicemicin_46 # 44437 # 45528 # 1 # ID=1_46;partial=00;start_type=TTG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.712	BGC0000202.1|Azicemicin_46 	44437	45528	+	Loose	550	26.1794	SHV-143	30.59	3001344	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	TTGTCTGACCTGCTGGTCGCCCCCTCGTTGACCGGAGTGCTGGACGGCCTTCCCGCCGGGTCGTCCGGCCGGGACGTCTGGCGGGCGCTCGGCCGGGCCGGGGTCATCGAGCAGGTCGGTTCGAGCCCTGAGCCGGACCGGCTCGCCCACCTGCTCGCCGCGGTGGACCGGCGTTTCCCTGTCGGCACCACGCTGGCGGTGTGCGTGCAGGTGGCGACCGTGCTGCCGATCCTCGCCACCGGCCCCGCCGACGTGCTGCGCAGGGCACAGACGGGGATCGACACGATCGCCTTCGCGGCCACCGATGTCGGTTCCGGCTCGGACCTGACCGCGCTGCGCACCGGGGTCCGGCTCGGCGACGACGGGATCGAGGTCACCGGGGACAAGCGCTGGATCACCAACGCGACCACGGCCGACGCGTTCCTGGTGCTGGCCAGACACAAGGCGGGACGGCACTTCTCCAGCTTCACGTGGGTGCTTGTCCCTGCCTCCGCGCCGGGCGTGACGGTCACTCCGGCGGACACGACGTTGTTCGAGGGCTCCGGTGTCGGTCACGTGCGGTTCGACCGGGTGTTCTCCGGGCAGGTCATCGGACGCCCTGGCCGTGGCATGACCACGTTCGCACGGCACATCGGGACCGAACGCCTCGCTGGTGGACTGTGGTCGGTGGCGTTGTGCCGACGCGTGCTGGCCGACACGCTGCAACGCCTGTCCACGCGTTCCCACGGTGAGAACACGCTGTGGCATGTGGACAGCGTTCGGCAGCGGTTCGCCGAATGCCTGGTCCGTGTCCGCCAGCTGGACGCGTTGACCAGGGAGGTTGGCAGGCGGATCGTGCGGGACCACGACGCCGCCGCGGCGGCGTTGGTGAAGGCCGCCGCGGCGAGCACCGTGGACCACGTCCTGGCCGAGTGCGCGCACCTGCAGGGCGCCGACGGGTTCTCGGACGGCGGTGTGCAGGAGCTTCGCGCGCAGGCCGGGCTGTTCGGCGTCGGCGGTGGCGTGACCGAGGTCGTTCTGTCCACTGTGGCCGATCAGGCGTCGGCGATACTGCGCGGGATGGACCGGGAATGTTCACCCGAACCCGGATAG	MSDLLVAPSLTGVLDGLPAGSSGRDVWRALGRAGVIEQVGSSPEPDRLAHLLAAVDRRFPVGTTLAVCVQVATVLPILATGPADVLRRAQTGIDTIAFAATDVGSGSDLTALRTGVRLGDDGIEVTGDKRWITNATTADAFLVLARHKAGRHFSSFTWVLVPASAPGVTVTPADTTLFEGSGVGHVRFDRVFSGQVIGRPGRGMTTFARHIGTERLAGGLWSVALCRRVLADTLQRLSTRSHGENTLWHVDSVRQRFAECLVRVRQLDALTREVGRRIVRDHDAAAAALVKAAAASTVDHVLAECAHLQGADGFSDGGVQELRAQAGLFGVGGGVTEVVLSTVADQASAILRGMDRECSPEPG	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDLWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	126.92	gnl|BL_ORD_ID|1442|hsp_num:0	1533		
BGC0000202.1|Azicemicin_47 # 45507 # 45995 # 1 # ID=1_47;partial=00;start_type=ATG;rbs_motif=GGGA;rbs_spacer=10bp;gc_cont=0.736	BGC0000202.1|Azicemicin_47 	45507	45995	+	Loose	1200	23.8682	TaeA	62.5	3003986	protein homolog model	n/a	n/a	pleuromutilin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTTCACCCGAACCCGGATAGTCCACGCCGACGCGGGACTGTGGATCGCCACCGCTCCCCTGCCGTCCGGGGTGCCGGAGTCGGCGGCGGGCCGCAGCCTGCTGCGTGCGTTGCTGCGCGTGGCCGCTCCGGCCGCGGCGGCGGACACCGTGGCGACGCGTCCCGGCGGCAAGCCGTATCTGCGCGAACACCCCAGGATCGGCATCAGCGTGTCGCACGACCGGGGCGCCGTCGCCGCGTGCGTCGGCGTCGGCCGTGCAGTCGGGATCGATGTGCAGGTCCCGGACGACTCGCGGGAGCGCGCGTGGGTGTGGACGGTCCGGGAGGCCCTTGTGAAGACCACCGGGGAGGGACTGGCAGGCAGACCGTGGGACATCGACGTTCCACCGGGGCGCGGGTCGGGCACGTGGCGGTCGTGCCGCTGGGTGAGCCTGCGCGGCCGGTCGCCGATCCCGGTCAGCTACGCGTACCGGAAGGAAGCCTCATGA	MFTRTRIVHADAGLWIATAPLPSGVPESAAGRSLLRALLRVAAPAAAADTVATRPGGKPYLREHPRIGISVSHDRGAVAACVGVGRAVGIDVQVPDDSRERAWVWTVREALVKTTGEGLAGRPWDIDVPPGRGSGTWRSCRWVSLRGRSPIPVSYAYRKEAS	MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQKLLKLNQTLETLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANYSRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVHSSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLEQYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEASGSKAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFDQIDGLIEDTESKLASIQSEMETAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS	25.00	gnl|BL_ORD_ID|2292|hsp_num:0	2522		
BGC0000202.1|Azicemicin_48 # 45992 # 46909 # 1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.693	BGC0000202.1|Azicemicin_48 	45992	46909	+	Loose	1450	28.1054	BahA	39.39	3003984	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	Bah amidohydrolase	ATGACCTCGTCGGCCGAGTTGAGCTGCTACACCACGAACCTCGCCGAGTACCTCACGTGGGAGGTCACCGACGTCCGATGGCACATCGCCTCGGCGATCCGACTGGGCGTGCGCACCGGCCCCGGCGCACGGCTGGTCTTCTCCCAGCACACCCGCATGGACCAGGGCCCGGATGGACAGGAACTGTCCTACCGGGGCGCACCGTCGTGGGACACGGCCCGTGCGGAGCTGGCGCGCGAACTGGCGCGGTCGGGGCAGGTGCTCGTGGTGACCGATGCCGCACACCTGCCGTGGTCGCCGTATCCGGACGACCAGCATGGTCCACATTGGGTACTCGTCCGCGCGCAGCGCAACGAGACATGGCTGGCCGTGGACAGGTTCAGCACGATGACCATGCACGGCAGGCAGCACCCGTTCGAGGGCTGGCTGACCGACGCCGAGTTGCGGCACGCCATGACGCCGATGCCCGGCCTGCCGGTCGCCGTACGCAATCGGGACGCCCACGCACTCGGCTCACAGGTCCCACTTCCTCCCGACACGTCCTACCGCTGGCTGGTCAAGGCAGCCGCATCGGCGCCCGACACCGACGAGTGGTCCGTCGACGCCCTGCCGACGTTGCGACGCCTGGCAGACCGGCTCACCGTCGACGACACCGCCGTCGTGGACACCGTGGACGACCTGTGGGCGGCCGGAGTGCACCAGCATTTCCGGCTGACCGCGTTGACCGAACGCGGACTGGCGCCGATGCCGCTGGTCCAGCCCGTGCTCGTGGCGTGGACCAAGCTCGCGCGGTCGCTGCGGTTCGCCGCCAAGTCGGTACAACGCGGCAAGCCACGGCCCGATCTGGTCGTGCCCGCGTTCGACCGGCTGATCACCACCACCGACAAACTGTGCACCGAACTGGTCGCGGAGGTATGA	MTSSAELSCYTTNLAEYLTWEVTDVRWHIASAIRLGVRTGPGARLVFSQHTRMDQGPDGQELSYRGAPSWDTARAELARELARSGQVLVVTDAAHLPWSPYPDDQHGPHWVLVRAQRNETWLAVDRFSTMTMHGRQHPFEGWLTDAELRHAMTPMPGLPVAVRNRDAHALGSQVPLPPDTSYRWLVKAAASAPDTDEWSVDALPTLRRLADRLTVDDTAVVDTVDDLWAAGVHQHFRLTALTERGLAPMPLVQPVLVAWTKLARSLRFAAKSVQRGKPRPDLVVPAFDRLITTTDKLCTELVAEV	MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHGVGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDAAPDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS	40.56	gnl|BL_ORD_ID|2291|hsp_num:0	2521		
BGC0000202.1|Azicemicin_49 # 46914 # 48380 # 1 # ID=1_49;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=9bp;gc_cont=0.678	BGC0000202.1|Azicemicin_49 	46914	48380	+	Loose	750	28.4906	cmlA9	31.88	3005043	protein homolog model	n/a	n/a		antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAGACCATGTACGACTGGTTCGCCGCGTCCGTGGCCGACGGACCCGACCGGATCGCGCTGGAGATCGGCCAGGACCAGGTGACCTACCGCGAACTGTCCGACCTCGCCGACCACATCGCCGGTCAGCTGGTCACACGGATCGGTGGCGTGCCCCGCCGGGTCGGGCTCCTGGCGGCTCGCACTGCCCTCGCGTACGCCGGTTACCTGGCCATCCAGCGCCTTGGCGCGACCGCGATCCCGCTCAACCCCACGTTCCCGCCCGCCCGCAACGCCACGATCGCCCACCTGGCCGCGATGGACGTGGCGCTCACCGACCAGCAAGCGCCCGAGCTCCCGGTTCCCGTGGTGACAGCACGGCAGGCCGACGGTCCGCCGCCCGCGCTCCCCGCGTCGACGGCCACGGCCGAGGACATCGCGTACATCCTGTTCACCTCGGGGTCGACCGGGGCACCGAAGGGCGTGTGCGTCGCGCACCGGAACGTCACCGCGTACCTGTCACACGTGATCCCGCGCTACGAGGCAGGTCCGGGCGCGCGGTTCTCCCAGTTCTTCGAGTTGACGTTCGATCCGTCGGTGTACGACATGTTCACCGCGTGGGGCTCCGGCGCCACCTTGGTTGTGCCTGCACGCGGTGAGTTGCTGGCGCCGGTGCGGTTCGTCGACCGCGGCCGTGTGACGCACTGGAACTCCGTGCCGTCGGTGATCTCGCTGGCGCACCGCATGAAGGCGTTGAAACCAGGCAGCATGCCGACCTTGCGGTGGAGCATGTTCTGCGGTGAACCGCTCACGCTGCAGCAGGCCGAGGCTTGGCAGGCCGCGGCGTCCGGCAGCGTCGTGGAGAACATCTACGGGCCGACGGAGATGACCGTGACCTGTACCGAGTACCGGTTGCCGCGCGCGGACTGGCCGCAGCCGCCGAACGGGACGGTCCCGATCGGCACCCCGTATCCGGGGCTGGAGCACCTCATCCTGGACGACGGTGAACTGTGCTTGCGCGGGCCGCAACGATTCCCTGGCTATCTCGACACAGCAGACAACGTGGGCCGATTCCTTACCGAGGACAGGGAAATCTACGACGGCTCGACCGAACTCACCGACGCGCACTGGTACCGCACCGGTGACCGAGTAGCCAGTTTCGCCGGTCAGTTGGTGCACATCGGACGGATCGATCACCAGGTGAAAATCCGCGGCTACCGGGTGGAACTGGGTGAAATCGAGGCAGTGCTGCGCAGGCAGCCTGGCGTCGCCGACGCGGTGGTCCTCGCGATGCCCGGTCGCGGCGAAACCGAACTCGTCGCTGCCTATACGGGCACACCACAGGACGAAGAAGTCCTCCTCACCGCGCTGAGTACCGCACTGCCCGCGTACATGGTGCCGCGCACAGTCACCGCGTTCGACGCGTTCCCACTGAACCAGAACGGAAAGGTAGACCGTCGAGCGCTCACCGACTCGCTCGTCGCCTGA	MQTMYDWFAASVADGPDRIALEIGQDQVTYRELSDLADHIAGQLVTRIGGVPRRVGLLAARTALAYAGYLAIQRLGATAIPLNPTFPPARNATIAHLAAMDVALTDQQAPELPVPVVTARQADGPPPALPASTATAEDIAYILFTSGSTGAPKGVCVAHRNVTAYLSHVIPRYEAGPGARFSQFFELTFDPSVYDMFTAWGSGATLVVPARGELLAPVRFVDRGRVTHWNSVPSVISLAHRMKALKPGSMPTLRWSMFCGEPLTLQQAEAWQAAASGSVVENIYGPTEMTVTCTEYRLPRADWPQPPNGTVPIGTPYPGLEHLILDDGELCLRGPQRFPGYLDTADNVGRFLTEDREIYDGSTELTDAHWYRTGDRVASFAGQLVHIGRIDHQVKIRGYRVELGEIEAVLRRQPGVADAVVLAMPGRGETELVAAYTGTPQDEEVLLTALSTALPAYMVPRTVTAFDAFPLNQNGKVDRRALTDSLVA	MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGVLNTTPSIIQLTLSLYMVMLGVGQVIFGPLSDRVGRRPILLVGATAFVAASLGAACSSTALAFVAFRLVQAVGASAMLVATFATVRDVYANRPEGAVIYGLFSSMLAFVPALGPIAGALIGEFWGWQAIFITLAALASLALLNASFRWHETRPLDQARTQRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAGYSEIGFSLAFATVALVMVTTTRFAKSFVAKWGIAGCVARGMALLVSGAILLGIGQLFGSPSFFSFILPMWVVAVGIVFTVSVTANGALAQFDDIAGSAVAFYFCIQSLIVSIVGTLAVTLLNGDTAWPVICYATAMAVLVSLGLALLRSRDAATEKSPVV	120.79	gnl|BL_ORD_ID|2832|hsp_num:0	3786		
BGC0000202.1|Azicemicin_50 # 48649 # 50100 # 1 # ID=1_50;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=7bp;gc_cont=0.668	BGC0000202.1|Azicemicin_50 	48649	50100	+	Loose	900	273.478	lmrB	35.16	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTCAGATGTGCTCCAGGAACGACCGGCCAGATCGGGCGGCCGCACACCCACTGTGGTGCGGCTGCTGGTGCTGGCCACGTTCGTGGTGATCCTCAACGAGACCATCATGATCAACGCCATTCCCCGGCTGATGGAGTCGTTGCACGTCACCGAGCAGTCGGCGCAGTGGGTCTCCACCGCCTTCATGCTGACCATGGCCGCCGTCATCCCGACGACCGGATGGTTCCTGCAGCGGGTCACCACCCGGCAGGCGTACGCGCTGGCCATGGGCGCGTTCATCGTCGGCACGATCGTGTCCGCGGTCGCGCCGACGTTCGCGGTGCTGCTCATCGGCCGGATCATCCAGGCAGGCGGCACGGCAGTGATGTTGCCGCTGCTGATCACCACCCTGATGACGGTCGTTCCCGAAGAGGACCGCGGCCAGGTGATGGGCAACGTCATGCTGGCGATATCCGTGGCGCCCGCGCTCGGCCCGACAGTGTCCGGTCTGATCCTGCAGGTCGGGTCCTGGCGGCTGCTGTTCGTCGTCGTGCTGCCGATCGCGGCGCTGGTGACCGTGTTCGGGCTGCGCAAGATGATCAACATCGGCGAGCCCGTGATCAGTTCCATCGACTGGTTCAGTGTCGTGCTGGCCGCGCTCGGCTTCGGCGGCTTCGTCTATGGCCTGAGCTTGTTCGGCGAGGCCAAGAGCGGCCTCGGCATCGGCTTCGTCGTCGCCGGGCTCGCGATCACCGCGGTGTTCGTGTTCCGTCAGCTCAAGCTGCAGCGCACCGACTCGCCGCTGCTGGATCTGCGCACCCTGAAGGTCGGCACGTTCCGGATCGCACTGGGACTGACGGCCGTCGGATTCCTGGCGATGCTCAGCGCGATGGTCCTGCTGCCGCTGTACCTGCAGAACCTGCGTGGCCTGAGCCCGCTGCAGACCGGTTTCCTCGTCATGCCGGGTGGTCTGGCCATGGGGCTGCTCGGCCCGACCATCGGCAGGTTGTTCGACCGGTTCGGCGCGAGGCCGCTGGTGATCCCCGGCGCGATCGGCATGGTGGTGGCGTTGGCCGGGTTCACCCAGATCTCGGCGACGATGCCGTACTGGCAGATCCTGGGCCTGCACGTGCTGCTGATGCTGAGCCTGGCCGCGATGTTCACCCCGGTGTTCACGCTCGGCATGGGCGACGTCCCCGCGCACCTGTACTCGCACGGCAGCTCCATACTGGGCGCGCTGCAGCAGGTCGCAGGCGCGTTCGGCACGGCGCTGGTGATCACCATCCTGACCACGCGGGTCACCAGCCTGACAGCTGAAGGTGTGGCCATCGCGGACGCGCAGCTGAGTGGTATGCGCATCGCCTTCATCGTCGCGACCGTCATTGCCTTGTTCACGATCATCCTCGCGCTGAGGCTGCCGAACCGGCCAACCACCAGCAGCGAGGGCGAGGTCAGCGCTCCCGTGCACTAG	MSDVLQERPARSGGRTPTVVRLLVLATFVVILNETIMINAIPRLMESLHVTEQSAQWVSTAFMLTMAAVIPTTGWFLQRVTTRQAYALAMGAFIVGTIVSAVAPTFAVLLIGRIIQAGGTAVMLPLLITTLMTVVPEEDRGQVMGNVMLAISVAPALGPTVSGLILQVGSWRLLFVVVLPIAALVTVFGLRKMINIGEPVISSIDWFSVVLAALGFGGFVYGLSLFGEAKSGLGIGFVVAGLAITAVFVFRQLKLQRTDSPLLDLRTLKVGTFRIALGLTAVGFLAMLSAMVLLPLYLQNLRGLSPLQTGFLVMPGGLAMGLLGPTIGRLFDRFGARPLVIPGAIGMVVALAGFTQISATMPYWQILGLHVLLMLSLAAMFTPVFTLGMGDVPAHLYSHGSSILGALQQVAGAFGTALVITILTTRVTSLTAEGVAIADAQLSGMRIAFIVATVIALFTIILALRLPNRPTTSSEGEVSAPVH	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	101.26	gnl|BL_ORD_ID|554|hsp_num:0	592		
BGC0000202.1|Azicemicin_51 # 50097 # 50393 # -1 # ID=1_51;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.714	BGC0000202.1|Azicemicin_51 	50097	50393	-	Loose	2090	27.335	mdsB	34.09	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GCTGTGGCGGCCACCTTGCTGTCGTCCGCCGAGCCGCCGGACGCGATCGCCGCGATGAGCGATCAGCAGGCCGCCGGGGTTGTCCGCGCGGCGCGTGCCGCTGGCCGCGCCATCCCCGATGACCTCGCTGTGACCGGGTGGGACGACGCGGCCGTCGCGGCACAACTAGGCCTGACGACCGTCGCACAGTCCCTACGCGACCAGGGCGCGGCCTGCGCACAGGCCGCGCTTGGTCAGAAACCGGACTCGTATGCCGGAGCCTGGTCGGTTGTTCGCCGTACAAGCACCCGTGACTAG	AVAATLLSSAEPPDAIAAMSDQQAAGVVRAARAAGRAIPDDLAVTGWDDAAVAAQLGLTTVAQSLRDQGAACAQAALGQKPDSYAGAWSVVRRTSTRD	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	9.29	gnl|BL_ORD_ID|1301|hsp_num:0	1385		
BGC0000202.1|Azicemicin_36 # 34613 # 35755 # -1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=AGGG;rbs_spacer=8bp;gc_cont=0.714	BGC0000202.1|Azicemicin_36 	34613	35755	-	Loose	650	40.817	Enterococcus faecium liaS mutant conferring daptomycin resistance	24.09	3003079	protein variant model	E192G	n/a	peptide antibiotic	antibiotic target alteration; antibiotic efflux	daptomycin resistant liaS	ATGGTGGCGCGGCTCTGGGGTGGTGGTGCCGCAGTCTGTCTGGTCGGACTCGCGGTGTTGTCGGTGCCGAGAACAGGGCCGGTGATCACGATCGCCGGGGCGCTGGTCGTCGCCGCGCTGGTGTTGACCGCCGTGGTGCGCCGGTTCCTGGTGCTGGCAACAGGGGCGGCTGCCGCAGTGTCGTTGACAGCAACAGGTCTGCTCGCGGTGTCACCACCGCCACCGTTGCACAACACGGCCGCGGCCTGGTTGTTGGCCGAGTTGGCGGCTCTGCTGGTACTGCTCGCGATCGTGCTGCGGCGTACGGAGTCGCGCCGCGCGGCCTACGTCACGCTGTTCGCTGTTCTCGCGGCGACGGCGCTGCCGATGCGCGTGGCAGTGGACTCTGCCCCACCAGCCAGTGTGCTGGAGTTGGCAGTGCTGGGCGGGCTGGGTGTTCTCCCGGCCGTGGCCGCTGTGCTGGCGGGCGGCTACCTGCGCGTGCTCGACGGACGCCGTGTGCGCGCTGTCGCGGAGACACGAGCGGCCCAGCGCCGACGACTTGCCTATGACCTGCATGACTTCGTCGGTCACGACCTGAACGCGATCGTGCTCGAGGCGCAGGCCGCGCTGCTGGTGCCGGGTCGCGCGCGGGACGCGCTGGCCAGGATCGAGGAGGCAGGCCAGGCCGCGCTGTCGGCCATGGACCAGACGCTGCGGATGCTGGCGGCGGACGCGGTCGGCGGTGACGAGCGTGGCATGGGAATCACCGATCTCGACCAGGTGGTCGGTCGGTTCGGCGAGTGGGGTCCGGCGCGTCCGCGGTTGCGGGTCGAGGAGGTGGGGCCGGTACCGCGCGAGGTCGGCGCGGTCGTCTACCGGATCGTGGTCGAGTCACTGACCAACGTGCGTCGGCACGCTCCGGACGCGACCGAGATCTCTGTCGAGGTGACCGCGGTGCCCGGCCCTGCGGTGTGCGTGTCGGTGACCGACGACGGCCACCATGTCTCCGGCCCCGGACCGCGACGCGGACGTGGGCTCGGCATCGTCGGACTGACCGAACACGTCGAGCTTCTCGGCGGGCGGCTCACCGCCGGTCGACGGCAGCCGTCGGGGTGGCAGGTCGTGGCGACGATCCCCACCGCAACGGTGGTGCGGTCATGA	MVARLWGGGAAVCLVGLAVLSVPRTGPVITIAGALVVAALVLTAVVRRFLVLATGAAAAVSLTATGLLAVSPPPPLHNTAAAWLLAELAALLVLLAIVLRRTESRRAAYVTLFAVLAATALPMRVAVDSAPPASVLELAVLGGLGVLPAVAAVLAGGYLRVLDGRRVRAVAETRAAQRRRLAYDLHDFVGHDLNAIVLEAQAALLVPGRARDALARIEEAGQAALSAMDQTLRMLAADAVGGDERGMGITDLDQVVGRFGEWGPARPRLRVEEVGPVPREVGAVVYRIVVESLTNVRRHAPDATEISVEVTAVPGPAVCVSVTDDGHHVSGPGPRRGRGLGIVGLTEHVELLGGRLTAGRRQPSGWQVVATIPTATVVRS	MMGKISRAMLAVYSGIAAFLIILFSLFTYFYASNQSHWWGELLRARLLYVPLIFHLLAISLGVGLIVFLLLSLIQKTKYGKIEEKLRALSSGNYESKLLLLPIPSASDDLYIKDIDKEITKIKEKMIEVSSELQIVTSRPQYVDGQTKEEILELERHRLARELHDSVSQQLFAAMMMMSALTEQAEKSETPEMFRKQLKMVAEIINASQSEMRALLLHLRPVNLEEKSLKQGIEQLLKELQNKIQISLKWDVEDVKLSSSIEDHLFRIVQELLSNTLRHAKANELEVYLHKIDNNLLLRIIDDGTGFNMNETKTGSYGLNNIKERVAGIGGTVKIISFKGQGTSVEIKVPLMKEA	107.04	gnl|BL_ORD_ID|1999|hsp_num:0	1108		
